Catalent, Inc. (CTLT) NYSE
$60.32 (0.03) (-0.05%)
Market Cap: $10.95B
As of 09/18/24 04:00 PM EDT. Market closed.
Catalent, Inc. (CTLT)
NYSE
$60.32
(0.03) (-0.05%)
Market Cap: $10.95B
As of 09/18/24 04:00 PM EDT. Market closed.
Add to Portfolio
Catalent is a leading provider of advanced development and manufacturing solutions for a wide array of health products, including drugs, biologics, cell and gene therapies, and consumer health products. Operating over fifty facilities across four continents, Catalent offers innovative technologies such as oral, injectable, and respiratory delivery systems, along with robust capabilities in ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Alessandro Maselli
Full Time Employees
18,000
CEO Compensation (Base)
$925,000
CEO Compensation (Total)
$6.58M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Alessandro Maselli
Full Time Employees
18,000
CEO Compensation (Base)
$925,000
CEO Compensation (Total)
$6.58M
URL
Address
14 Schoolhouse Road, NJ, Somerset, 08873.
PRICE CHART FOR CATALENT, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$60.35
Previous Close
$60.35
Days Range
$60.12 - $60.47
52 week range
$31.80 - $61.20
Volume
2,431,479
Avg. Volume (30 days)
1,847,748
Market Cap
$10.95B
Dividend Yield
-
P/E
(10.47)
Shares Outstanding
181,464,000
Open
$60.35
Previous Close
$60.35
Days Range
$60.12 - $60.47
52 week range
$31.80 - $61.20
Volume
2,431,479
Avg. Volume (30 days)
1,847,748
Market Cap
$10.95B
Dividend Yield
-
P/E
(10.47)
Shares Outstanding
181,464,000
FINANCIAL STATEMENTS FOR CATALENT, INC.
LOADING...
INSIDER TRANSACTIONS FOR CATALENT, INC.
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Hopson Ricky | Pres. BioProduct Delivery, CoS | Aug 02, 2024 | Sale | $59.56 | 662 | 39,429 | 29,974 | Aug 05, 2024, 12:55 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Aug 02, 2024 | Sale | $59.55 | 666 | 39,660 | 39,635 | Aug 05, 2024, 12:51 PM |
Ferraro Joseph Anthony | SVP, General Counsel, CCO | Aug 02, 2024 | Sale | $59.58 | 608 | 36,225 | 24,287 | Aug 05, 2024, 12:45 PM |
Evoli Lisa | SVP, Chief HR Officer | Aug 02, 2024 | Sale | $59.67 | 3,859 | 230,267 | 39,366 | Aug 05, 2024, 12:39 PM |
Gennadios Aristippos | Group Pres. Pharma & Consumer | Aug 02, 2024 | Sale | $59.55 | 1,169 | 69,614 | 113,724 | Aug 05, 2024, 12:33 PM |
Maselli Alessandro | President & CEO | Jul 29, 2024 | Sale | $58.76 | 9,088 | 534,011 | 177,521 | Jul 30, 2024, 04:53 PM |
Hopson Ricky | Pres. BioProduct Delivery, CoS | Jul 29, 2024 | Sale | $58.67 | 206 | 12,086 | 30,636 | Jul 30, 2024, 04:45 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Jul 29, 2024 | Sale | $58.69 | 283 | 16,609 | 40,301 | Jul 30, 2024, 04:39 PM |
Gennadios Aristippos | Group Pres. Pharma & Consumer | Jul 29, 2024 | Sale | $58.70 | 349 | 20,486 | 114,893 | Jul 30, 2024, 04:30 PM |
Masanovich Matti | SVP, Chief Financial Officer | Jul 08, 2024 | Sale | $56.74 | 2,993 | 169,823 | 33,871 | Jul 10, 2024, 04:56 PM |
Hopson Ricky | Pres. BioProduct Delivery, CoS | Jun 04, 2024 | Sale | $54.26 | 1,401 | 76,023 | 20,617 | Jun 05, 2024, 09:35 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Mar 15, 2024 | Sale | $56.20 | 387 | 21,749 | 29,506 | Mar 19, 2024, 01:38 PM |
Kreuzburg Christa | Director | Jan 25, 2024 | Option Exercise | $50.41 | 523 | 26,364 | 18,283 | Jan 29, 2024, 04:09 PM |
Gennadios Aristippos | Group Pres. Pharma & Consumer | Dec 08, 2023 | Option Exercise | $37.18 | 367 | 13,645 | 96,496 | Dec 12, 2023, 07:28 PM |
Maselli Alessandro | President & CEO | Dec 08, 2023 | Option Exercise | $37.18 | 1,924 | 71,534 | 87,938 | Dec 12, 2023, 07:27 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Dec 08, 2023 | Option Exercise | $37.18 | 250 | 9,295 | 29,893 | Dec 12, 2023, 07:26 PM |
Hopson Ricky | Pres. Clinical Dev Supply Div | Dec 08, 2023 | Option Exercise | $37.18 | 256 | 9,518 | 22,018 | Dec 12, 2023, 07:24 PM |
Kreuzburg Christa | Director | Oct 27, 2023 | Option Exercise | $39.32 | 1,245 | 48,953 | 18,806 | Oct 31, 2023, 04:32 PM |
Hunt Patricia | Pres. Consumer Health Div | Oct 16, 2023 | Option Exercise | $46.52 | 22 | 1,023 | 11,267 | Oct 18, 2023, 02:38 PM |
Ryan Michelle R | Director | Aug 31, 2023 | Buy | $49.98 | 1,000 | 49,980 | 1,979 | Sep 05, 2023, 06:00 PM |
GREISCH JOHN J | Executive Chair | Aug 30, 2023 | Buy | $50.24 | 21,000 | 1,055,040 | 34,000 | Sep 01, 2023, 01:52 PM |
Maselli Alessandro | President & CEO | Aug 24, 2023 | Sale | $44.54 | 2,071 | 92,245 | 88,105 | Aug 25, 2023, 07:16 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Aug 24, 2023 | Sale | $44.57 | 269 | 11,989 | 29,932 | Aug 25, 2023, 07:12 PM |
Grippo Michael J | SVP, Strategy & Corp. Dev. | Aug 24, 2023 | Sale | $44.50 | 390 | 17,355 | 24,449 | Aug 25, 2023, 07:08 PM |
Gennadios Aristippos | Group Pres. Pharma & Consumer | Aug 24, 2023 | Sale | $44.49 | 396 | 17,618 | 96,552 | Aug 25, 2023, 07:05 PM |
Fasman Steven L | EVP & Chief Admin Officer | Aug 24, 2023 | Sale | $44.65 | 817 | 36,479 | 73,789 | Aug 25, 2023, 07:02 PM |
Carletti Lorenzo | SVP Global Ops Ph & Cons Hlth | Aug 24, 2023 | Sale | $44.71 | 216 | 9,657 | 8,746 | Aug 25, 2023, 06:58 PM |
Arnold Jonathan | SVP, CCO & Div. Head BioP Del. | Aug 24, 2023 | Sale | $44.87 | 87 | 3,904 | 57,399 | Aug 25, 2023, 06:56 PM |
Hopson Ricky | Pres. Clinical Dev Supply Div | Aug 24, 2023 | Sale | $44.56 | 276 | 12,299 | 22,040 | Aug 25, 2023, 06:52 PM |
Hawkeswood Thomas W | Pres. Pharma Prod Delivery Div | Aug 24, 2023 | Sale | $44.72 | 147 | 6,574 | 7,533 | Aug 25, 2023, 06:48 PM |
Lickfold Charles | SVP, CIO | Aug 24, 2023 | Sale | $44.72 | 190 | 8,497 | 11,339 | Aug 25, 2023, 06:45 PM |
Hunt Patricia | Pres. Consumer Health Div | Aug 24, 2023 | Sale | $44.77 | 106 | 4,746 | 11,289 | Aug 25, 2023, 06:39 PM |
Pravda Ricardo | Chief Transformation Officer | Aug 24, 2023 | Sale | $44.47 | 379 | 16,854 | 30,224 | Aug 25, 2023, 06:37 PM |
Pravda Ricardo | Chief Transformation Officer | Aug 01, 2023 | Sale | $47.56 | 269 | 12,793 | 19,961 | Aug 03, 2023, 05:13 PM |
Maselli Alessandro | President & CEO | Aug 01, 2023 | Sale | $47.13 | 1,485 | 69,995 | 86,707 | Aug 03, 2023, 05:05 PM |
Lickfold Charles | SVP, CIO | Aug 01, 2023 | Sale | $47.90 | 135 | 6,467 | 5,570 | Aug 03, 2023, 05:00 PM |
Hunt Patricia | Pres. Consumer Health Div | Aug 01, 2023 | Sale | $47.95 | 161 | 7,720 | 9,154 | Aug 03, 2023, 04:51 PM |
Hopson Ricky | Pres. Clinical Dev Supply Div | Aug 01, 2023 | Sale | $47.86 | 195 | 9,333 | 16,257 | Aug 03, 2023, 04:47 PM |
Hawkeswood Thomas W | Pres. Pharma Prod Delivery Div | Aug 01, 2023 | Sale | $47.97 | 258 | 12,376 | 5,106 | Aug 03, 2023, 04:41 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Aug 01, 2023 | Sale | $47.90 | 190 | 9,101 | 23,798 | Aug 03, 2023, 04:37 PM |
Grippo Michael J | SVP, Strategy & Corp. Dev. | Aug 01, 2023 | Sale | $47.72 | 276 | 13,171 | 17,757 | Aug 03, 2023, 04:30 PM |
Gennadios Aristippos | Group Pres. Pharma & Consumer | Aug 01, 2023 | Sale | $47.59 | 281 | 13,373 | 86,708 | Aug 03, 2023, 04:21 PM |
Carletti Lorenzo | SVP Global Ops Ph & Cons Hlth | Aug 01, 2023 | Sale | $47.77 | 383 | 18,296 | 4,602 | Aug 03, 2023, 04:16 PM |
Arnold Jonathan | SVP, CCO & Div. Head BioP Del. | Aug 01, 2023 | Sale | $47.80 | 62 | 2,964 | 55,896 | Aug 03, 2023, 04:09 PM |
Fasman Steven L | EVP & Chief Admin Officer | Aug 01, 2023 | Sale | $47.05 | 1,637 | 77,026 | 60,740 | Aug 03, 2023, 04:02 PM |
Boerman Manja | Pres. BioModalities Division | May 01, 2023 | Sale | $49.86 | 1,446 | 72,098 | 14,414 | May 03, 2023, 07:00 PM |
Gargiulo Mario | SVP, Ops, Biologics Europe | May 01, 2023 | Sale | $49.86 | 678 | 33,805 | 5,676 | May 03, 2023, 06:58 PM |
Hopson Ricky | Pres. Clinical Dev Supply Div | Jan 23, 2023 | Sale | $49.36 | 643 | 31,738 | 16,452 | Jan 25, 2023, 05:06 PM |
Boerman Manja | Pres. BioModalities Division | Dec 05, 2022 | Sale | $51.70 | 780 | 40,326 | 15,860 | Dec 07, 2022, 04:51 PM |
Grippo Michael J | SVP, Strategy & Corp. Dev. | Oct 31, 2022 | Sale | $65.83 | 2,451 | 161,349 | 17,792 | Nov 02, 2022, 07:58 PM |
Kreuzburg Christa | Director | Oct 27, 2022 | Option Exercise | $66.27 | 421 | 27,900 | 13,058 | Oct 31, 2022, 05:01 PM |
Hawkeswood Thomas W | Pres. Pharma Prod Delivery Div | Oct 10, 2022 | Sale | $77.46 | 930 | 72,038 | 5,364 | Oct 12, 2022, 06:13 PM |
Hopson Ricky | Pres. Clinical Dev Supply Div | Aug 31, 2022 | Sale | $89.59 | 2,216 | 198,531 | 17,095 | Sep 02, 2022, 02:43 PM |
Riley Michael A. | Pres. Bio Product Delivery Div | Aug 26, 2022 | Sale | $104.07 | 2,491 | 259,238 | 6,592 | Aug 30, 2022, 02:38 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Aug 26, 2022 | Sale | $104.07 | 1,639 | 170,571 | 23,988 | Aug 30, 2022, 02:37 PM |
Schmidt Kay A | SVP, Enterprise Functions | Aug 25, 2022 | Sale | $103.04 | 1,321 | 136,116 | 17,388 | Aug 26, 2022, 08:23 PM |
Riley Michael A. | Pres. Bio Product Delivery Div | Aug 25, 2022 | Sale | $103.04 | 1,482 | 152,705 | 9,083 | Aug 26, 2022, 08:23 PM |
Pravda Ricardo | SVP & Chief HR Officer | Aug 25, 2022 | Sale | $103.04 | 1,747 | 180,011 | 20,008 | Aug 26, 2022, 08:21 PM |
Maselli Alessandro | President & CEO | Aug 25, 2022 | Sale | $103.04 | 4,646 | 478,724 | 41,190 | Aug 26, 2022, 08:20 PM |
Hunt Patricia | Pres. Consumer Health Div | Aug 25, 2022 | Sale | $103.04 | 339 | 34,931 | 9,315 | Aug 26, 2022, 08:20 PM |
Hopson Ricky | Pres. Clinical Dev Supply Div | Aug 25, 2022 | Sale | $103.04 | 1,517 | 156,312 | 19,311 | Aug 26, 2022, 08:19 PM |
Hawkeswood Thomas W | Pres. Pharma Prod Delivery Div | Aug 25, 2022 | Sale | $103.04 | 671 | 69,140 | 6,294 | Aug 26, 2022, 08:19 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Aug 25, 2022 | Sale | $103.04 | 1,840 | 189,594 | 25,627 | Aug 26, 2022, 08:18 PM |
Grippo Michael J | SVP, Strategy & Corp. Dev. | Aug 25, 2022 | Sale | $103.04 | 1,670 | 172,077 | 20,243 | Aug 26, 2022, 08:18 PM |
Gennadios Aristippos | Group Pres. Pharma & Consumer | Aug 25, 2022 | Sale | $103.04 | 1,645 | 169,501 | 86,769 | Aug 26, 2022, 08:17 PM |
Gargiulo Mario | SVP Global Ops Biologics | Aug 25, 2022 | Sale | $103.04 | 1,586 | 163,421 | 6,354 | Aug 26, 2022, 08:17 PM |
Fasman Steven L | EVP & Chief Admin Officer | Aug 25, 2022 | Sale | $103.04 | 4,811 | 495,725 | 61,853 | Aug 26, 2022, 08:16 PM |
Chiminski John R | Executive Chair | Aug 25, 2022 | Sale | $103.04 | 38,934 | 4,011,759 | 229,888 | Aug 26, 2022, 08:16 PM |
Castellano Thomas P | SVP, Chief Financial Officer | Aug 25, 2022 | Sale | $103.04 | 1,414 | 145,699 | 20,099 | Aug 26, 2022, 08:16 PM |
Carletti Lorenzo | SVP Global Ops Ph & Cons Hlth | Aug 25, 2022 | Sale | $103.04 | 1,033 | 106,440 | 4,985 | Aug 26, 2022, 08:15 PM |
Boerman Manja | Pres. BioModalities Division | Aug 25, 2022 | Sale | $103.04 | 3,296 | 339,620 | 16,640 | Aug 26, 2022, 08:15 PM |
Arnold Jonathan | SVP & Chief Commercial Ofcr | Aug 25, 2022 | Sale | $103.04 | 384 | 39,567 | 55,958 | Aug 26, 2022, 08:14 PM |
Schmidt Kay A | SVP, Enterprise Functions | Jul 26, 2022 | Sale | $106.90 | 323 | 34,529 | 13,455 | Jul 28, 2022, 08:03 PM |
Pravda Ricardo | SVP & Chief HR Officer | Jul 26, 2022 | Sale | $106.90 | 427 | 45,646 | 15,337 | Jul 28, 2022, 08:01 PM |
Maselli Alessandro | President & CEO | Jul 26, 2022 | Sale | $106.90 | 816 | 87,230 | 25,083 | Jul 28, 2022, 08:00 PM |
Hopson Ricky | Pres, Clinical Dev & Supply | Jul 27, 2022 | Sale | $107.67 | 591 | 63,633 | 17,095 | Jul 28, 2022, 07:59 PM |
Hopson Ricky | Pres, Clinical Dev & Supply | Jul 26, 2022 | Sale | $106.90 | 312 | 33,353 | 17,035 | Jul 28, 2022, 07:59 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Jul 27, 2022 | Sale | $107.67 | 394 | 42,422 | 22,350 | Jul 28, 2022, 07:58 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Jul 26, 2022 | Sale | $106.90 | 450 | 48,105 | 21,629 | Jul 28, 2022, 07:58 PM |
Grippo Michael J | SVP, Strategy & Corp. Dev. | Jul 27, 2022 | Sale | $107.67 | 388 | 41,776 | 17,023 | Jul 28, 2022, 07:46 PM |
Grippo Michael J | SVP, Strategy & Corp. Dev. | Jul 26, 2022 | Sale | $106.90 | 409 | 43,722 | 16,110 | Jul 28, 2022, 07:46 PM |
Gennadios Aristippos | Group Pres. Pharma & Consumer | Jul 26, 2022 | Sale | $106.90 | 403 | 43,081 | 79,784 | Jul 28, 2022, 07:45 PM |
Gargiulo Mario | SVP Global Ops Biologics | Jul 26, 2022 | Sale | $106.90 | 969 | 103,586 | 3,671 | Jul 28, 2022, 07:43 PM |
Fasman Steven L | EVP & Chief Admin Officer | Jul 26, 2022 | Sale | $106.90 | 2,546 | 272,167 | 53,721 | Jul 28, 2022, 07:42 PM |
Chiminski John R | Executive Chair | Jul 26, 2022 | Sale | $106.90 | 9,691 | 1,035,968 | 132,382 | Jul 28, 2022, 07:41 PM |
Castellano Thomas P | SVP, Chief Financial Officer | Jul 26, 2022 | Sale | $106.90 | 347 | 37,094 | 15,051 | Jul 28, 2022, 07:39 PM |
Carletti Lorenzo | SVP Global Ops Ph & Cons Hlth | Jul 26, 2022 | Sale | $106.90 | 631 | 67,454 | 2,949 | Jul 28, 2022, 07:39 PM |
Arnold Jonathan | SVP & Chief Commercial Ofcr | Jul 26, 2022 | Sale | $106.90 | 94 | 10,049 | 48,698 | Jul 28, 2022, 07:35 PM |
Gennadios Aristippos | Group Pres. Pharma & Consumer | Jul 01, 2022 | Option Exercise | $107.02 | 18,689 | 2,000,097 | 80,187 | Jul 05, 2022, 09:46 PM |
Arnold Jonathan | SVP & Chief Commercial Ofcr | Jul 01, 2022 | Option Exercise | $107.02 | 2,804 | 300,084 | 48,792 | Jul 05, 2022, 09:46 PM |
Gargiulo Mario | SVP Global Ops Large Molecule | Jun 10, 2022 | Sale | $106.59 | 118 | 12,578 | 4,640 | Jun 13, 2022, 04:58 PM |
Fasman Steven L | SVP & General Counsel | Jun 10, 2022 | Sale | $107.07 | 5,000 | 535,352 | 58,129 | Jun 13, 2022, 04:57 PM |
Zippelius Peter | Director | Feb 06, 2022 | Sale | $102.65 | 487,092 | 49,999,995 | 4,330,462 | Feb 08, 2022, 09:31 PM |
Hopson Ricky | VP, Chief Accounting Officer | Jan 31, 2022 | Sale | $103.39 | 2,325 | 240,382 | 17,073 | Feb 01, 2022, 03:38 PM |
Whitlow Ricci S | President, CSS | Jan 21, 2022 | Sale | $102.37 | 184 | 18,836 | 2,923 | Jan 24, 2022, 04:42 PM |
Flynn Karen | Chief Commercial Officer | Jan 10, 2022 | Sale | $116.64 | 2,472 | 288,334 | 33,223 | Jan 11, 2022, 06:54 PM |
Zippelius Peter | Director | Nov 18, 2021 | Option Exercise | $49.54 | 7,822,946 | 387,555,795 | 7,822,946 | Dec 01, 2021, 08:35 PM |
Zippelius Peter | Director | Nov 30, 2021 | Sale | $129.30 | 3,000,000 | 387,900,009 | 4,822,946 | Dec 01, 2021, 08:35 PM |
CARROLL J MARTIN | Director | Nov 29, 2021 | Option Exercise | $134.12 | 3,136 | 420,600 | 11,663 | Dec 01, 2021, 01:41 PM |
CARROLL J MARTIN | Director | Nov 29, 2021 | Option Exercise | $134.12 | 3,136 | 420,600 | 0 | Dec 01, 2021, 01:41 PM |
LUCIER GREGORY T | Director | Nov 23, 2021 | Sale | $127.35 | 5,068 | 645,407 | 2,400 | Nov 24, 2021, 12:40 PM |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | Nov 01, 2021 | Option Exercise | $44.77 | 7,559 | 338,421 | 52,643 | Nov 03, 2021, 03:35 PM |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | Nov 01, 2021 | Sale | $140.02 | 10,672 | 1,494,293 | 41,971 | Nov 03, 2021, 03:35 PM |
Kreuzburg Christa | Director | Oct 28, 2021 | Option Exercise | $135.50 | 638 | 86,449 | 9,330 | Nov 01, 2021, 08:00 AM |
Castellano Thomas P | SVP, Chief Financial Officer | Oct 20, 2021 | Sale | $134.00 | 2,307 | 309,138 | 15,398 | Oct 21, 2021, 07:16 PM |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | Oct 14, 2021 | Sale | $129.41 | 1,661 | 214,950 | 45,084 | Oct 18, 2021, 02:33 PM |
Schmidt Kay A | SVP, Technical Operations | Oct 04, 2021 | Sale | $131.25 | 2,191 | 287,569 | 13,778 | Oct 06, 2021, 05:37 PM |
Fasman Steven L | SVP & General Counsel | Oct 04, 2021 | Option Exercise | $51.51 | 17,259 | 889,050 | 91,847 | Oct 06, 2021, 05:37 PM |
Fasman Steven L | SVP & General Counsel | Oct 04, 2021 | Sale | $129.05 | 34,714 | 4,479,975 | 71,334 | Oct 06, 2021, 05:37 PM |
Pravda Ricardo | SVP & Chief HR Officer | Oct 01, 2021 | Option Exercise | $63.30 | 3,818 | 241,694 | 16,653 | Oct 05, 2021, 06:51 PM |
Pravda Ricardo | SVP & Chief HR Officer | Oct 01, 2021 | Sale | $132.68 | 4,906 | 650,928 | 11,747 | Oct 05, 2021, 06:51 PM |
Grippo Michael J | SVP, Strategy & Corp. Dev. | Oct 01, 2021 | Sale | $131.66 | 2,055 | 270,557 | 14,357 | Oct 05, 2021, 06:51 PM |
Chiminski John R | Chair & CEO | Oct 01, 2021 | Option Exercise | $39.39 | 75,838 | 2,986,973 | 294,710 | Oct 05, 2021, 06:51 PM |
Chiminski John R | Chair & CEO | Oct 01, 2021 | Sale | $130.90 | 152,637 | 19,979,610 | 290,109 | Oct 05, 2021, 06:51 PM |
Kreuzburg Christa | Director | Aug 27, 2021 | Option Exercise | $129.85 | 199 | 25,840 | 8,566 | Aug 31, 2021, 05:28 PM |
Castellano Thomas P | SVP, Chief Financial Officer | Aug 27, 2021 | Sale | $131.13 | 2,093 | 274,458 | 19,640 | Aug 30, 2021, 09:43 PM |
Schmidt Kay A | SVP, Technical Operations | Aug 27, 2021 | Sale | $131.13 | 825 | 108,183 | 16,731 | Aug 30, 2021, 09:43 PM |
Hopson Ricky | VP, Chief Accounting Officer | Aug 27, 2021 | Sale | $131.13 | 1,471 | 192,894 | 20,758 | Aug 30, 2021, 09:42 PM |
Pravda Ricardo | SVP & Chief HR Officer | Aug 27, 2021 | Sale | $131.13 | 692 | 90,742 | 13,474 | Aug 30, 2021, 09:42 PM |
Maselli Alessandro | President & COO | Aug 27, 2021 | Sale | $131.13 | 3,743 | 490,824 | 29,359 | Aug 30, 2021, 09:41 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Aug 27, 2021 | Sale | $130.78 | 4,173 | 545,725 | 22,062 | Aug 30, 2021, 09:41 PM |
Grippo Michael J | SVP, Strategy & Corp. Dev. | Aug 27, 2021 | Sale | $131.13 | 1,698 | 222,661 | 16,127 | Aug 30, 2021, 09:40 PM |
Gennadios Aristippos | President Softgel & Oral Tech | Aug 27, 2021 | Sale | $131.13 | 2,262 | 296,619 | 59,572 | Aug 30, 2021, 09:40 PM |
Fasman Steven L | SVP & General Counsel | Aug 27, 2021 | Sale | $131.13 | 6,111 | 801,344 | 80,238 | Aug 30, 2021, 09:39 PM |
Chiminski John R | Chair & CEO | Aug 27, 2021 | Sale | $131.06 | 44,488 | 5,830,710 | 270,760 | Aug 30, 2021, 09:39 PM |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | Aug 27, 2021 | Sale | $131.13 | 452 | 59,271 | 47,162 | Aug 30, 2021, 09:38 PM |
Grippo Michael J | SVP, Strategy & Corp. Dev. | Dec 19, 2019 | Sale | $54.00 | 1,846 | 99,684 | 15,733 | Aug 23, 2021, 06:35 PM |
Grippo Michael J | SVP, Strategy & Corp. Dev. | Jan 13, 2020 | Sale | $58.00 | 1,680 | 97,440 | 11,647 | Aug 23, 2021, 06:35 PM |
Grippo Michael J | SVP, Strategy & Corp. Dev. | Dec 20, 2019 | Sale | $56.00 | 2,406 | 134,736 | 13,327 | Aug 23, 2021, 06:35 PM |
Castellano Thomas P | SVP, Chief Financial Officer | Jul 26, 2021 | Sale | $113.05 | 555 | 62,743 | 14,463 | Jul 28, 2021, 04:29 PM |
Schmidt Kay A | SVP, Technical Operations | Jul 26, 2021 | Sale | $113.05 | 547 | 61,838 | 13,319 | Jul 28, 2021, 04:29 PM |
Hopson Ricky | VP, Chief Accounting Officer | Jul 26, 2021 | Sale | $113.05 | 360 | 40,698 | 16,056 | Jul 28, 2021, 04:28 PM |
Pravda Ricardo | SVP & Chief HR Officer | Jul 26, 2021 | Sale | $113.05 | 458 | 51,777 | 10,612 | Jul 28, 2021, 04:28 PM |
Maselli Alessandro | President & COO | Jul 26, 2021 | Sale | $113.05 | 993 | 112,259 | 18,625 | Jul 28, 2021, 04:28 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Jul 26, 2021 | Sale | $113.04 | 1,079 | 121,967 | 15,900 | Jul 28, 2021, 04:27 PM |
Grippo Michael J | SVP, Strategy & Corp. Dev. | Jul 26, 2021 | Sale | $113.05 | 451 | 50,986 | 16,605 | Jul 28, 2021, 04:27 PM |
Gennadios Aristippos | President Softgel & Oral Tech | Jul 26, 2021 | Sale | $113.05 | 465 | 52,568 | 50,850 | Jul 28, 2021, 04:27 PM |
Fasman Steven L | SVP & General Counsel | Jul 26, 2021 | Sale | $113.05 | 1,549 | 175,114 | 67,363 | Jul 28, 2021, 04:26 PM |
Chiminski John R | Chair & CEO | Jul 26, 2021 | Sale | $113.05 | 11,137 | 1,259,038 | 152,481 | Jul 28, 2021, 04:25 PM |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | Jul 26, 2021 | Sale | $113.05 | 120 | 13,566 | 38,482 | Jul 28, 2021, 04:25 PM |
Fasman Steven L | SVP & General Counsel | Jul 15, 2021 | Sale | $109.86 | 4,500 | 494,353 | 70,099 | Jul 16, 2021, 01:06 PM |
Pravda Ricardo | SVP & Chief HR Officer | Jun 23, 2021 | Sale | $110.58 | 2,800 | 309,624 | 11,070 | Jun 24, 2021, 06:10 PM |
Schmidt Kay A | SVP, Technical Operations | Mar 22, 2021 | Sale | $105.77 | 1,400 | 148,078 | 13,866 | Mar 23, 2021, 07:27 PM |
Fasman Steven L | SVP & General Counsel | Mar 18, 2021 | Option Exercise | $38.78 | 21,647 | 839,445 | 94,954 | Mar 22, 2021, 02:20 PM |
Fasman Steven L | SVP & General Counsel | Mar 18, 2021 | Sale | $104.53 | 21,647 | 2,262,770 | 82,039 | Mar 22, 2021, 02:20 PM |
Chiminski John R | Chair & CEO | Mar 19, 2021 | Option Exercise | $42.06 | 183,024 | 7,698,674 | 346,642 | Mar 22, 2021, 02:19 PM |
Chiminski John R | Chair & CEO | Mar 18, 2021 | Option Exercise | $36.02 | 42,220 | 1,520,764 | 205,838 | Mar 22, 2021, 02:19 PM |
Chiminski John R | Chair & CEO | Mar 19, 2021 | Sale | $106.01 | 183,024 | 19,402,784 | 276,059 | Mar 22, 2021, 02:19 PM |
Chiminski John R | Chair & CEO | Mar 18, 2021 | Sale | $105.16 | 42,220 | 4,439,855 | 163,618 | Mar 22, 2021, 02:19 PM |
Joseph Wetteny | SVP & Chief Financial Officer | Feb 16, 2021 | Option Exercise | $52.56 | 5,000 | 262,799 | 54,823 | Feb 18, 2021, 09:56 AM |
Joseph Wetteny | SVP & Chief Financial Officer | Feb 16, 2021 | Sale | $124.54 | 5,000 | 622,685 | 53,024 | Feb 18, 2021, 09:56 AM |
Joseph Wetteny | SVP & Chief Financial Officer | Feb 08, 2021 | Sale | $113.73 | 4,604 | 523,613 | 49,823 | Feb 10, 2021, 09:05 AM |
Whitlow Ricci S | President, CSS | Jan 21, 2021 | Sale | $118.85 | 692 | 82,244 | 2,576 | Jan 25, 2021, 07:17 AM |
Flynn Karen | Pres. Biologics & CCO | Jan 11, 2021 | Sale | $112.30 | 2,478 | 278,279 | 35,644 | Jan 11, 2021, 07:12 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Jan 06, 2021 | Sale | $104.78 | 61 | 6,392 | 16,509 | Jan 07, 2021, 07:04 AM |
Whitlow Ricci S | President, CSS | Jan 04, 2021 | Sale | $104.42 | 83 | 8,667 | 3,268 | Jan 05, 2021, 09:47 PM |
Schmidt Kay A | SVP, Technical Operations | Jan 04, 2021 | Sale | $104.42 | 73 | 7,623 | 15,266 | Jan 05, 2021, 09:47 PM |
Pravda Ricardo | SVP & Chief HR Officer | Jan 04, 2021 | Sale | $104.42 | 78 | 8,145 | 13,870 | Jan 05, 2021, 09:46 PM |
Maselli Alessandro | President & COO | Jan 04, 2021 | Sale | $104.42 | 148 | 15,454 | 19,618 | Jan 05, 2021, 09:46 PM |
Joseph Wetteny | SVP & Chief Financial Officer | Jan 04, 2021 | Sale | $104.42 | 172 | 17,960 | 54,427 | Jan 05, 2021, 09:46 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Jan 04, 2021 | Sale | $104.42 | 120 | 12,530 | 16,570 | Jan 05, 2021, 09:45 PM |
Grippo Michael J | SVP, Strategy & Corp. Dev. | Jan 04, 2021 | Sale | $104.42 | 126 | 13,157 | 17,076 | Jan 05, 2021, 09:45 PM |
Gennadios Aristippos | President Softgel & Oral Tech | Jan 04, 2021 | Sale | $104.42 | 110 | 11,486 | 51,315 | Jan 05, 2021, 09:45 PM |
Flynn Karen | Pres. Biologics & CCO | Jan 04, 2021 | Sale | $104.42 | 99 | 10,338 | 37,022 | Jan 05, 2021, 09:44 PM |
Fasman Steven L | SVP & General Counsel | Jan 04, 2021 | Sale | $104.42 | 189 | 19,735 | 73,307 | Jan 05, 2021, 09:44 PM |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | Jan 04, 2021 | Sale | $104.42 | 16 | 1,671 | 38,602 | Jan 05, 2021, 09:44 PM |
Gennadios Aristippos | President Softgel & Oral Tech | Dec 21, 2020 | Option Exercise | $32.68 | 13,662 | 446,526 | 61,151 | Dec 23, 2020, 07:19 AM |
Gennadios Aristippos | President Softgel & Oral Tech | Dec 21, 2020 | Sale | $102.84 | 13,662 | 1,405,044 | 51,425 | Dec 23, 2020, 07:19 AM |
Zippelius Peter | Director | Nov 23, 2020 | Option Exercise | $49.54 | 5,392,280 | 267,138,411 | 5,392,280 | Nov 25, 2020, 05:53 PM |
Zippelius Peter | Director | Nov 23, 2020 | Sale | $99.26 | 5,392,280 | 535,237,724 | 0 | Nov 25, 2020, 05:53 PM |
Fasman Steven L | SVP & General Counsel | Nov 11, 2020 | Sale | $100.99 | 2,425 | 244,901 | 73,496 | Nov 12, 2020, 12:21 PM |
Schmidt Kay A | SVP, Technical Operations | Oct 23, 2020 | Option Exercise | $94.02 | 425 | 39,958 | 15,339 | Oct 26, 2020, 06:51 PM |
Schmidt Kay A | SVP, Technical Operations | Oct 14, 2020 | Sale | $93.15 | 2,985 | 278,045 | 17,564 | Oct 16, 2020, 06:13 PM |
Fasman Steven L | SVP & General Counsel | Oct 14, 2020 | Option Exercise | $93.10 | 9,515 | 885,883 | 81,431 | Oct 16, 2020, 06:13 PM |
Fasman Steven L | SVP & General Counsel | Oct 14, 2020 | Option Exercise | $26.18 | 15,025 | 393,426 | 87,460 | Oct 16, 2020, 06:13 PM |
Fasman Steven L | SVP & General Counsel | Oct 14, 2020 | Sale | $93.09 | 5,510 | 512,934 | 78,942 | Oct 16, 2020, 06:13 PM |
Grippo Michael J | SVP, Strategy & Corp. Dev. | Oct 12, 2020 | Sale | $94.99 | 1,680 | 159,583 | 17,202 | Oct 13, 2020, 08:24 AM |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | Oct 07, 2020 | Option Exercise | $91.50 | 23,414 | 2,142,381 | 54,546 | Oct 09, 2020, 03:24 PM |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | Oct 07, 2020 | Option Exercise | $30.84 | 39,342 | 1,213,364 | 77,960 | Oct 09, 2020, 03:24 PM |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | Oct 07, 2020 | Sale | $91.50 | 15,928 | 1,457,412 | 38,618 | Oct 09, 2020, 03:24 PM |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | Oct 04, 2020 | Option Exercise | $85.88 | 240 | 20,611 | 38,618 | Oct 06, 2020, 09:25 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Oct 02, 2020 | Option Exercise | $84.94 | 5,200 | 441,688 | 21,049 | Oct 05, 2020, 07:55 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Oct 02, 2020 | Option Exercise | $36.02 | 7,347 | 264,639 | 26,249 | Oct 05, 2020, 07:55 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Oct 02, 2020 | Sale | $85.48 | 4,359 | 372,608 | 18,384 | Oct 05, 2020, 07:55 PM |
Chiminski John R | Chair & CEO | Oct 02, 2020 | Option Exercise | $86.01 | 86,251 | 7,418,449 | 355,849 | Oct 05, 2020, 07:55 PM |
Chiminski John R | Chair & CEO | Oct 02, 2020 | Option Exercise | $29.90 | 138,135 | 4,130,817 | 404,337 | Oct 05, 2020, 07:55 PM |
Chiminski John R | Chair & CEO | Oct 02, 2020 | Sale | $86.01 | 182,231 | 15,673,809 | 346,658 | Oct 05, 2020, 07:55 PM |
Grippo Michael J | SVP, Strategy & Corp. Dev. | Sep 02, 2020 | Sale | $89.50 | 2,250 | 201,378 | 18,888 | Sep 08, 2020, 01:21 PM |
Schmidt Kay A | SVP, Technical Operations | Aug 27, 2020 | Option Exercise | $87.71 | 904 | 79,290 | 18,749 | Aug 31, 2020, 05:25 PM |
Pravda Ricardo | SVP & Chief HR Officer | Aug 27, 2020 | Option Exercise | $87.71 | 943 | 82,711 | 11,699 | Aug 31, 2020, 05:24 PM |
Maselli Alessandro | President & COO | Aug 27, 2020 | Option Exercise | $87.71 | 4,217 | 369,873 | 19,766 | Aug 31, 2020, 05:24 PM |
Joseph Wetteny | SVP & Chief Financial Officer | Aug 27, 2020 | Option Exercise | $87.71 | 3,480 | 305,231 | 54,599 | Aug 31, 2020, 05:24 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Aug 27, 2020 | Option Exercise | $87.71 | 2,823 | 247,605 | 18,902 | Aug 31, 2020, 05:23 PM |
Grippo Michael J | SVP, Strategy & Corp. Dev. | Aug 27, 2020 | Option Exercise | $87.71 | 2,392 | 209,802 | 21,132 | Aug 31, 2020, 05:23 PM |
Gennadios Aristippos | President Softgel & Oral Tech | Aug 27, 2020 | Option Exercise | $87.71 | 4,384 | 384,521 | 51,425 | Aug 31, 2020, 05:23 PM |
Fasman Steven L | SVP & General Counsel | Aug 27, 2020 | Option Exercise | $87.71 | 6,676 | 585,552 | 75,883 | Aug 31, 2020, 05:22 PM |
Chiminski John R | Chair & CEO | Aug 27, 2020 | Option Exercise | $87.71 | 58,978 | 5,172,960 | 303,965 | Aug 31, 2020, 05:22 PM |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | Aug 27, 2020 | Option Exercise | $87.71 | 3,023 | 265,147 | 38,858 | Aug 31, 2020, 05:21 PM |
Kreuzburg Christa | Director | Aug 22, 2020 | Option Exercise | $86.49 | 951 | 82,252 | 5,979 | Aug 24, 2020, 06:16 PM |
Chiminski John R | Chair & CEO | Aug 23, 2020 | Option Exercise | $86.49 | 4,649 | 402,092 | 223,918 | Aug 24, 2020, 06:15 PM |
LUCIER GREGORY T | Director | Jul 30, 2020 | Sale | $90.09 | 24,000 | 2,162,160 | 16,921 | Aug 03, 2020, 12:02 PM |
Schmidt Kay A | SVP, Technical Operations | Jul 24, 2020 | Option Exercise | $81.64 | 504 | 41,147 | 11,517 | Jul 28, 2020, 08:12 AM |
Pravda Ricardo | SVP & Chief HR Officer | Jul 24, 2020 | Option Exercise | $81.64 | 1,949 | 159,116 | 9,123 | Jul 28, 2020, 08:12 AM |
Maselli Alessandro | President & COO | Jul 24, 2020 | Option Exercise | $81.64 | 940 | 76,742 | 12,177 | Jul 28, 2020, 08:11 AM |
Joseph Wetteny | SVP & Chief Financial Officer | Jul 24, 2020 | Option Exercise | $81.64 | 761 | 62,128 | 46,015 | Jul 28, 2020, 08:11 AM |
Gunther Scott | SVP, Quality & Reg. Affairs | Jul 24, 2020 | Option Exercise | $81.64 | 646 | 52,739 | 12,719 | Jul 28, 2020, 08:11 AM |
Grippo Michael J | SVP, Strategy & Corp. Dev. | Jul 24, 2020 | Option Exercise | $81.64 | 532 | 43,432 | 15,750 | Jul 28, 2020, 08:11 AM |
Gennadios Aristippos | President Softgel & Oral Tech | Jul 24, 2020 | Option Exercise | $81.64 | 984 | 80,334 | 43,536 | Jul 28, 2020, 08:10 AM |
Fasman Steven L | SVP & General Counsel | Jul 24, 2020 | Option Exercise | $81.64 | 1,227 | 100,172 | 62,039 | Jul 28, 2020, 08:10 AM |
Chiminski John R | Chair & CEO | Jul 24, 2020 | Option Exercise | $81.64 | 6,642 | 542,253 | 207,965 | Jul 28, 2020, 08:10 AM |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | Jul 24, 2020 | Option Exercise | $81.64 | 3,796 | 309,905 | 30,713 | Jul 28, 2020, 08:09 AM |
Gunther Scott | SVP, Quality & Reg. Affairs | Jun 29, 2020 | Sale | $72.00 | 2,824 | 203,318 | 13,765 | Jul 01, 2020, 06:15 PM |
Gennadios Aristippos | President Softgel & Oral Tech | Jun 25, 2020 | Option Exercise | $73.00 | 13,930 | 1,016,890 | 52,845 | Jun 29, 2020, 06:54 PM |
Gennadios Aristippos | President Softgel & Oral Tech | Jun 25, 2020 | Option Exercise | $27.97 | 22,255 | 622,541 | 59,736 | Jun 29, 2020, 06:54 PM |
Gennadios Aristippos | President Softgel & Oral Tech | Jun 25, 2020 | Sale | $73.00 | 8,325 | 607,725 | 44,520 | Jun 29, 2020, 06:54 PM |
CARROLL J MARTIN | Director | May 12, 2020 | Option Exercise | $72.29 | 3,600 | 260,244 | 8,527 | May 13, 2020, 05:08 PM |
CARROLL J MARTIN | Director | May 12, 2020 | Option Exercise | $72.29 | 3,600 | 260,244 | 0 | May 13, 2020, 05:08 PM |
Whitlow Ricci S | President, CSS | Apr 09, 2020 | Option Exercise | $56.46 | 240 | 13,550 | 2,704 | Apr 13, 2020, 12:22 PM |
Schmidt Kay A | SVP, Technical Operations | Apr 09, 2020 | Option Exercise | $56.46 | 226 | 12,760 | 12,021 | Apr 13, 2020, 12:22 PM |
Pravda Ricardo | SVP & Chief HR Officer | Apr 09, 2020 | Option Exercise | $56.46 | 226 | 12,760 | 11,072 | Apr 13, 2020, 12:21 PM |
Maselli Alessandro | President & COO | Apr 09, 2020 | Option Exercise | $56.46 | 315 | 17,785 | 13,117 | Apr 13, 2020, 12:21 PM |
Joseph Wetteny | SVP & Chief Financial Officer | Apr 09, 2020 | Option Exercise | $56.46 | 349 | 19,705 | 46,776 | Apr 13, 2020, 12:20 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Apr 09, 2020 | Option Exercise | $56.46 | 243 | 13,720 | 16,189 | Apr 13, 2020, 12:20 PM |
Grippo Michael J | SVP, Strategy & Corp. Dev. | Apr 09, 2020 | Option Exercise | $56.46 | 256 | 14,454 | 16,282 | Apr 13, 2020, 12:20 PM |
Gennadios Aristippos | President Softgel & Oral Tech | Apr 09, 2020 | Option Exercise | $56.46 | 279 | 15,752 | 44,520 | Apr 13, 2020, 12:19 PM |
Flynn Karen | Pres. Biologics & CCO | Apr 09, 2020 | Option Exercise | $56.46 | 359 | 20,269 | 35,645 | Apr 13, 2020, 12:19 PM |
Fasman Steven L | SVP & General Counsel | Apr 09, 2020 | Option Exercise | $56.46 | 386 | 21,794 | 63,206 | Apr 13, 2020, 12:19 PM |
BUZY PETER L | President, Gene Therapy | Apr 09, 2020 | Option Exercise | $56.46 | 266 | 15,018 | 45,950 | Apr 13, 2020, 12:12 PM |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | Apr 09, 2020 | Option Exercise | $56.46 | 264 | 14,905 | 34,509 | Apr 13, 2020, 12:12 PM |
LUCIER GREGORY T | Director | Feb 13, 2020 | Buy | $59.71 | 2,000 | 119,420 | 40,921 | Feb 14, 2020, 02:43 PM |
Schmidt Kay A | SVP, Technical Operations | Feb 02, 2020 | Option Exercise | $61.10 | 207 | 12,648 | 11,795 | Feb 04, 2020, 06:22 PM |
Maselli Alessandro | President & COO | Dec 16, 2019 | Sale | $53.18 | 7,268 | 386,512 | 12,802 | Dec 18, 2019, 08:51 AM |
Pravda Ricardo | SVP & Chief HR Officer | Nov 26, 2019 | Sale | $52.73 | 2,612 | 137,718 | 12,161 | Nov 27, 2019, 11:36 AM |
Gennadios Aristippos | President Softgel & Oral Tech | Nov 25, 2019 | Option Exercise | $52.55 | 78,615 | 4,131,218 | 89,497 | Nov 27, 2019, 11:36 AM |
Gennadios Aristippos | President Softgel & Oral Tech | Nov 25, 2019 | Option Exercise | $18.35 | 123,880 | 2,272,760 | 141,122 | Nov 27, 2019, 11:36 AM |
Gennadios Aristippos | President Softgel & Oral Tech | Nov 25, 2019 | Sale | $52.55 | 45,256 | 2,378,203 | 44,241 | Nov 27, 2019, 11:36 AM |
Grippo Michael J | SVP, Strategy & Corp. Dev. | Nov 22, 2019 | Sale | $52.00 | 376 | 19,552 | 10,702 | Nov 26, 2019, 05:07 PM |
Chiminski John R | Chair & CEO | Oct 07, 2019 | Option Exercise | $48.84 | 34,089 | 1,664,907 | 321,300 | Oct 09, 2019, 01:13 PM |
Chiminski John R | Chair & CEO | Oct 07, 2019 | Option Exercise | $24.40 | 47,552 | 1,160,409 | 348,387 | Oct 09, 2019, 01:13 PM |
Chiminski John R | Chair & CEO | Oct 07, 2019 | Sale | $48.84 | 97,043 | 4,739,580 | 224,257 | Oct 09, 2019, 01:13 PM |
LUCIER GREGORY T | Director | Sep 09, 2019 | Buy | $51.64 | 2,000 | 103,280 | 38,921 | Sep 11, 2019, 08:30 AM |
Maselli Alessandro | President & COO | Sep 09, 2019 | Option Exercise | $52.48 | 3,299 | 173,132 | 20,070 | Sep 11, 2019, 08:19 AM |
Schmidt Kay A | SVP, Technical Operations | Aug 22, 2019 | Option Exercise | $55.24 | 1,153 | 63,692 | 12,002 | Aug 26, 2019, 03:51 PM |
Pravda Ricardo | SVP, Human Resources | Aug 22, 2019 | Option Exercise | $55.24 | 1,218 | 67,282 | 13,458 | Aug 26, 2019, 03:50 PM |
Maselli Alessandro | President & COO | Aug 22, 2019 | Option Exercise | $55.24 | 5,466 | 301,942 | 23,369 | Aug 26, 2019, 03:50 PM |
Littlejohns Barry | President, Biologics & SDD | Aug 22, 2019 | Option Exercise | $55.24 | 7,178 | 396,513 | 45,882 | Aug 26, 2019, 03:49 PM |
Kreuzburg Christa | Director | Aug 23, 2019 | Option Exercise | $53.15 | 1,255 | 66,703 | 6,930 | Aug 26, 2019, 03:49 PM |
Joseph Wetteny | SVP & Chief Financial Officer | Aug 22, 2019 | Option Exercise | $55.24 | 4,176 | 230,682 | 46,427 | Aug 26, 2019, 03:48 PM |
HEGWOOD PAUL W JR | President, CSS | Aug 22, 2019 | Option Exercise | $55.24 | 1,069 | 59,052 | 11,848 | Aug 26, 2019, 03:48 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Aug 22, 2019 | Option Exercise | $55.24 | 1,317 | 72,751 | 15,946 | Aug 26, 2019, 03:48 PM |
Gennadios Aristippos | President, Softgel Tech. | Aug 22, 2019 | Option Exercise | $55.24 | 3,805 | 210,188 | 44,232 | Aug 26, 2019, 03:47 PM |
Fasman Steven L | SVP & General Counsel | Aug 22, 2019 | Option Exercise | $55.24 | 8,921 | 492,796 | 62,628 | Aug 26, 2019, 03:47 PM |
Chiminski John R | Chair & CEO | Aug 22, 2019 | Option Exercise | $55.24 | 51,767 | 2,859,609 | 307,837 | Aug 26, 2019, 03:45 PM |
Arnold Jonathan | President, Oral Drug Delivery | Aug 22, 2019 | Option Exercise | $55.24 | 2,765 | 152,739 | 34,245 | Aug 26, 2019, 03:44 PM |
Schmidt Kay A | SVP, Technical Operations | Jul 26, 2019 | Option Exercise | $57.26 | 1,079 | 61,784 | 9,558 | Jul 30, 2019, 04:22 PM |
Pravda Ricardo | SVP, Human Resources | Jul 26, 2019 | Option Exercise | $57.26 | 1,498 | 85,775 | 11,123 | Jul 30, 2019, 04:22 PM |
Maselli Alessandro | President & COO | Jul 26, 2019 | Option Exercise | $57.26 | 984 | 56,344 | 17,209 | Jul 30, 2019, 04:22 PM |
Littlejohns Barry | President, Biologics & SDD | Jul 26, 2019 | Option Exercise | $57.26 | 1,234 | 70,659 | 38,487 | Jul 30, 2019, 04:21 PM |
Joseph Wetteny | SVP & Chief Financial Officer | Jul 26, 2019 | Option Exercise | $57.26 | 954 | 54,626 | 39,342 | Jul 30, 2019, 04:21 PM |
HEGWOOD PAUL W JR | President, CSS | Jul 26, 2019 | Option Exercise | $57.26 | 1,318 | 75,469 | 9,180 | Jul 30, 2019, 04:21 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Jul 26, 2019 | Option Exercise | $57.26 | 1,626 | 93,105 | 13,419 | Jul 30, 2019, 04:20 PM |
Gennadios Aristippos | President, Softgel Tech. | Jul 26, 2019 | Option Exercise | $57.26 | 748 | 42,830 | 35,617 | Jul 30, 2019, 04:20 PM |
Fasman Steven L | SVP & General Counsel | Jul 26, 2019 | Option Exercise | $57.26 | 2,205 | 126,258 | 53,332 | Jul 30, 2019, 04:20 PM |
Chiminski John R | Chair & CEO | Jul 26, 2019 | Option Exercise | $57.26 | 13,333 | 763,448 | 240,384 | Jul 30, 2019, 04:19 PM |
Arnold Jonathan | President, Oral Drug Delivery | Jul 26, 2019 | Option Exercise | $57.26 | 2,394 | 137,080 | 28,000 | Jul 30, 2019, 04:19 PM |
CARROLL J MARTIN | Director | Jul 15, 2019 | Option Exercise | $53.24 | 4,927 | 262,313 | 4,927 | Jul 17, 2019, 06:53 PM |
CARROLL J MARTIN | Director | Jul 15, 2019 | Option Exercise | $53.24 | 4,927 | 262,313 | 0 | Jul 17, 2019, 06:53 PM |
Littlejohns Barry | President, Biologics & SDD | Jul 12, 2019 | Option Exercise | $53.54 | 33,272 | 1,781,383 | 53,658 | Jul 16, 2019, 07:21 PM |
Littlejohns Barry | President, Biologics & SDD | Jul 12, 2019 | Option Exercise | $19.36 | 49,212 | 952,938 | 67,562 | Jul 16, 2019, 07:21 PM |
Littlejohns Barry | President, Biologics & SDD | Jul 12, 2019 | Sale | $53.53 | 15,940 | 853,344 | 37,818 | Jul 16, 2019, 07:21 PM |
Fasman Steven L | SVP & General Counsel | Jul 11, 2019 | Option Exercise | $54.01 | 19,040 | 1,028,350 | 52,581 | Jul 15, 2019, 06:03 PM |
Fasman Steven L | SVP & General Counsel | Jul 11, 2019 | Option Exercise | $27.30 | 27,146 | 741,142 | 60,705 | Jul 15, 2019, 06:03 PM |
Fasman Steven L | SVP & General Counsel | Jul 11, 2019 | Sale | $54.04 | 4,053 | 219,024 | 48,528 | Jul 15, 2019, 06:03 PM |
BUZY PETER L | President, Gene Therapy | May 29, 2019 | Buy | $45.13 | 44,500 | 2,008,285 | 44,500 | May 30, 2019, 07:36 PM |
Joseph Wetteny | SVP & Chief Financial Officer | May 28, 2019 | Option Exercise | $46.23 | 4,677 | 216,218 | 37,383 | May 30, 2019, 06:54 PM |
Joseph Wetteny | SVP & Chief Financial Officer | May 28, 2019 | Option Exercise | $10.71 | 9,453 | 101,242 | 42,060 | May 30, 2019, 06:54 PM |
MOREL DONALD E JR | Director | May 15, 2019 | Buy | $44.44 | 10,000 | 444,400 | 46,958 | May 16, 2019, 07:51 PM |
LUCIER GREGORY T | Director | May 09, 2019 | Buy | $45.08 | 2,000 | 90,160 | 38,822 | May 13, 2019, 01:39 PM |
Gennadios Aristippos | President, Softgel Tech. | Mar 21, 2019 | Option Exercise | $42.17 | 6,744 | 284,385 | 39,068 | Mar 25, 2019, 05:50 PM |
Gennadios Aristippos | President, Softgel Tech. | Mar 21, 2019 | Option Exercise | $10.71 | 13,528 | 144,885 | 44,862 | Mar 25, 2019, 05:50 PM |
Gennadios Aristippos | President, Softgel Tech. | Mar 21, 2019 | Sale | $42.18 | 3,392 | 143,089 | 34,792 | Mar 25, 2019, 05:50 PM |
Miyamoto Lance | SVP, Human Resources | Mar 07, 2019 | Option Exercise | $42.64 | 79,991 | 3,410,816 | 90,418 | Mar 11, 2019, 07:31 PM |
Miyamoto Lance | SVP, Human Resources | Mar 07, 2019 | Option Exercise | $15.34 | 123,610 | 1,896,336 | 130,793 | Mar 11, 2019, 07:31 PM |
Miyamoto Lance | SVP, Human Resources | Mar 07, 2019 | Sale | $42.49 | 43,619 | 1,853,379 | 46,918 | Mar 11, 2019, 07:31 PM |
Kreuzburg Christa | Director | Feb 16, 2019 | Option Exercise | $42.03 | 358 | 15,047 | 5,018 | Feb 20, 2019, 03:53 PM |
Downie William | SVP, Global Sales & Marketing | Feb 15, 2019 | Option Exercise | $42.00 | 9,736 | 408,912 | 42,241 | Feb 20, 2019, 03:48 PM |
Downie William | SVP, Global Sales & Marketing | Feb 15, 2019 | Option Exercise | $24.69 | 12,457 | 307,505 | 45,231 | Feb 20, 2019, 03:48 PM |
Downie William | SVP, Global Sales & Marketing | Feb 15, 2019 | Sale | $42.00 | 7,315 | 307,230 | 34,926 | Feb 20, 2019, 03:48 PM |
Fasman Steven L | SVP & General Counsel | Jan 28, 2019 | Option Exercise | $36.49 | 5,199 | 189,712 | 44,475 | Jan 30, 2019, 01:29 PM |
GREISCH JOHN J | Director | Nov 08, 2018 | Buy | $37.61 | 13,000 | 488,930 | 13,000 | Nov 13, 2018, 08:28 AM |
Miyamoto Lance | SVP, Human Resources | Oct 16, 2018 | Option Exercise | $42.50 | 11,475 | 487,688 | 53,324 | Oct 18, 2018, 11:59 AM |
Miyamoto Lance | SVP, Human Resources | Oct 16, 2018 | Option Exercise | $12.14 | 18,000 | 218,520 | 64,799 | Oct 18, 2018, 11:59 AM |
Miyamoto Lance | SVP, Human Resources | Oct 16, 2018 | Sale | $42.50 | 6,525 | 277,313 | 46,799 | Oct 18, 2018, 11:59 AM |
Littlejohns Barry | President, Biologics & SDD | Oct 15, 2018 | Option Exercise | $41.64 | 97,546 | 4,061,815 | 84,983 | Oct 17, 2018, 12:28 PM |
Littlejohns Barry | President, Biologics & SDD | Oct 15, 2018 | Option Exercise | $14.86 | 144,811 | 2,151,891 | 125,218 | Oct 17, 2018, 12:28 PM |
Littlejohns Barry | President, Biologics & SDD | Oct 15, 2018 | Sale | $41.64 | 47,265 | 1,968,115 | 37,718 | Oct 17, 2018, 12:28 PM |
Joseph Wetteny | SVP & Chief Financial Officer | Oct 15, 2018 | Option Exercise | $41.47 | 303 | 12,565 | 32,607 | Oct 16, 2018, 03:55 PM |
Chiminski John R | Chair, President & CEO | Oct 01, 2018 | Option Exercise | $45.32 | 199,608 | 9,046,234 | 360,235 | Oct 03, 2018, 05:53 PM |
Chiminski John R | Chair, President & CEO | Oct 01, 2018 | Option Exercise | $21.05 | 286,358 | 6,027,735 | 416,074 | Oct 03, 2018, 05:53 PM |
Chiminski John R | Chair, President & CEO | Oct 01, 2018 | Sale | $45.32 | 130,545 | 5,916,299 | 229,690 | Oct 03, 2018, 05:53 PM |
MOREL DONALD E JR | Director | Sep 13, 2018 | Buy | $43.00 | 10,000 | 430,000 | 36,958 | Sep 17, 2018, 10:56 AM |
Miyamoto Lance | SVP, Human Resources | Aug 27, 2018 | Option Exercise | $43.66 | 987 | 43,092 | 46,799 | Sep 04, 2018, 07:53 PM |
Maselli Alessandro | SVP, Global Operations | Aug 27, 2018 | Option Exercise | $43.66 | 427 | 18,643 | 15,644 | Sep 04, 2018, 07:53 PM |
Littlejohns Barry | President, Biologics & SDD | Aug 27, 2018 | Option Exercise | $43.66 | 944 | 41,215 | 37,718 | Sep 04, 2018, 07:52 PM |
Joseph Wetteny | SVP & Chief Financial Officer | Aug 27, 2018 | Option Exercise | $43.66 | 502 | 21,917 | 32,910 | Sep 04, 2018, 07:51 PM |
HEGWOOD PAUL W JR | President, CSS | Aug 27, 2018 | Option Exercise | $43.66 | 505 | 22,048 | 9,587 | Sep 04, 2018, 07:51 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Aug 27, 2018 | Option Exercise | $43.66 | 590 | 25,759 | 13,807 | Sep 04, 2018, 07:50 PM |
Fasman Steven L | SVP & General Counsel | Aug 27, 2018 | Option Exercise | $43.66 | 1,063 | 46,411 | 49,674 | Sep 04, 2018, 07:50 PM |
Downie William | SVP, Global Sales & Marketing | Aug 27, 2018 | Option Exercise | $43.66 | 1,291 | 56,365 | 39,520 | Sep 04, 2018, 07:49 PM |
Chiminski John R | Chair, President & CEO | Aug 27, 2018 | Option Exercise | $43.66 | 9,783 | 427,126 | 278,353 | Sep 04, 2018, 07:48 PM |
Arnold Jonathan | President, Oral Drug Delivery | Aug 27, 2018 | Option Exercise | $43.66 | 518 | 22,616 | 32,696 | Sep 04, 2018, 07:48 PM |
Miyamoto Lance | SVP, Human Resources | Aug 27, 2018 | Option Exercise | $43.66 | 987 | 43,092 | 48,773 | Aug 29, 2018, 04:51 PM |
Maselli Alessandro | SVP, Global Operations | Aug 27, 2018 | Option Exercise | $43.66 | 427 | 18,643 | 16,498 | Aug 29, 2018, 04:51 PM |
Littlejohns Barry | President, Biologics & SDD | Aug 27, 2018 | Option Exercise | $43.66 | 944 | 41,215 | 39,606 | Aug 29, 2018, 04:50 PM |
Joseph Wetteny | SVP & Chief Financial Officer | Aug 27, 2018 | Option Exercise | $43.66 | 502 | 21,917 | 33,914 | Aug 29, 2018, 04:49 PM |
HEGWOOD PAUL W JR | President, CSS | Aug 27, 2018 | Option Exercise | $43.66 | 505 | 22,048 | 10,597 | Aug 29, 2018, 04:49 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Aug 27, 2018 | Option Exercise | $43.66 | 590 | 25,759 | 14,987 | Aug 29, 2018, 04:48 PM |
Fasman Steven L | SVP & General Counsel | Aug 27, 2018 | Option Exercise | $43.66 | 1,063 | 46,411 | 51,800 | Aug 29, 2018, 04:48 PM |
Downie William | SVP, Global Sales & Marketing | Aug 27, 2018 | Option Exercise | $43.66 | 1,291 | 56,365 | 42,102 | Aug 29, 2018, 04:47 PM |
Chiminski John R | Chair, President & CEO | Aug 27, 2018 | Option Exercise | $43.66 | 9,783 | 427,126 | 297,919 | Aug 29, 2018, 04:46 PM |
Arnold Jonathan | President, Oral Drug Delivery | Aug 27, 2018 | Option Exercise | $43.66 | 518 | 22,616 | 33,732 | Aug 29, 2018, 04:46 PM |
Miyamoto Lance | SVP, Human Resources | Aug 23, 2018 | Option Exercise | $41.83 | 2,129 | 89,056 | 47,786 | Aug 27, 2018, 05:25 PM |
Maselli Alessandro | SVP, Global Operations | Aug 23, 2018 | Option Exercise | $41.83 | 369 | 15,435 | 16,071 | Aug 27, 2018, 05:24 PM |
Littlejohns Barry | President, Biologics & SDD | Aug 23, 2018 | Option Exercise | $41.83 | 2,037 | 85,208 | 38,662 | Aug 27, 2018, 05:23 PM |
Joseph Wetteny | SVP & Chief Financial Officer | Aug 23, 2018 | Option Exercise | $41.83 | 1,835 | 76,758 | 33,412 | Aug 27, 2018, 05:23 PM |
HEGWOOD PAUL W JR | President, CSS | Aug 23, 2018 | Option Exercise | $41.83 | 435 | 18,196 | 10,092 | Aug 27, 2018, 05:22 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Aug 23, 2018 | Option Exercise | $41.83 | 511 | 21,375 | 14,397 | Aug 27, 2018, 05:22 PM |
Fasman Steven L | SVP & General Counsel | Aug 23, 2018 | Option Exercise | $41.83 | 2,295 | 96,000 | 50,737 | Aug 27, 2018, 05:20 PM |
Downie William | SVP, Global Sales & Marketing | Aug 23, 2018 | Option Exercise | $41.83 | 2,787 | 116,580 | 40,811 | Aug 27, 2018, 05:20 PM |
Chiminski John R | Chair, President & CEO | Aug 23, 2018 | Option Exercise | $41.83 | 17,561 | 734,577 | 288,136 | Aug 27, 2018, 05:19 PM |
Arnold Jonathan | President, Oral Drug Delivery | Aug 23, 2018 | Option Exercise | $41.83 | 1,117 | 46,724 | 33,214 | Aug 27, 2018, 05:19 PM |
Fasman Steven L | SVP & General Counsel | Jun 20, 2018 | Option Exercise | $41.78 | 10,954 | 457,658 | 45,568 | Jun 21, 2018, 12:46 PM |
Fasman Steven L | SVP & General Counsel | Jun 20, 2018 | Option Exercise | $24.26 | 15,458 | 375,011 | 56,522 | Jun 21, 2018, 12:46 PM |
Fasman Steven L | SVP & General Counsel | Jun 20, 2018 | Sale | $41.78 | 2,252 | 94,089 | 43,316 | Jun 21, 2018, 12:46 PM |
Downie William | SVP, Global Sales & Marketing | Mar 08, 2018 | Option Exercise | $40.95 | 12,965 | 530,917 | 44,475 | Mar 12, 2018, 11:44 AM |
Downie William | SVP, Global Sales & Marketing | Mar 08, 2018 | Option Exercise | $26.12 | 15,515 | 405,239 | 49,188 | Mar 12, 2018, 11:44 AM |
Downie William | SVP, Global Sales & Marketing | Mar 08, 2018 | Sale | $41.80 | 9,082 | 379,628 | 35,393 | Mar 12, 2018, 11:44 AM |
Chiminski John R | Chair, President & CEO | Dec 11, 2017 | Option Exercise | $39.70 | 125,227 | 4,971,512 | 411,539 | Dec 13, 2017, 02:37 PM |
Chiminski John R | Chair, President & CEO | Dec 11, 2017 | Option Exercise | $10.71 | 206,685 | 2,213,596 | 536,766 | Dec 13, 2017, 02:37 PM |
Chiminski John R | Chair, President & CEO | Dec 12, 2017 | Sale | $39.51 | 78,190 | 3,089,287 | 230,081 | Dec 13, 2017, 02:37 PM |
Chiminski John R | Chair, President & CEO | Dec 11, 2017 | Sale | $39.70 | 103,268 | 4,099,740 | 330,081 | Dec 13, 2017, 02:37 PM |
Roehrhoff Uwe | Director | Nov 21, 2017 | Buy | $39.22 | 7,500 | 294,150 | 16,489 | Nov 22, 2017, 04:25 PM |
Fasman Steven L | SVP & General Counsel | Oct 23, 2017 | Option Exercise | $42.74 | 1,602 | 68,469 | 36,064 | Oct 25, 2017, 12:32 PM |
Chiminski John R | Chair, President & CEO | Oct 23, 2017 | Option Exercise | $42.74 | 3,604 | 154,035 | 330,081 | Oct 25, 2017, 12:32 PM |
Chiminski John R | Chair, President & CEO | Sep 16, 2017 | Option Exercise | $39.49 | 22,039 | 870,320 | 333,685 | Sep 18, 2017, 07:53 PM |
Miyamoto Lance | SVP - Human Resources | Aug 29, 2017 | Option Exercise | $38.22 | 23,342 | 892,131 | 49,593 | Aug 31, 2017, 03:43 PM |
Miyamoto Lance | SVP - Human Resources | Aug 29, 2017 | Option Exercise | $12.14 | 39,138 | 475,135 | 60,935 | Aug 31, 2017, 03:43 PM |
Miyamoto Lance | SVP - Human Resources | Aug 29, 2017 | Sale | $38.22 | 8,512 | 325,329 | 41,081 | Aug 31, 2017, 03:43 PM |
Dolan Christine | SVP - Product Development | Aug 29, 2017 | Option Exercise | $38.75 | 5,964 | 231,105 | 21,043 | Aug 31, 2017, 10:41 AM |
Dolan Christine | SVP - Product Development | Aug 29, 2017 | Option Exercise | $18.57 | 9,150 | 169,915 | 27,007 | Aug 31, 2017, 10:41 AM |
Dolan Christine | SVP - Product Development | Aug 29, 2017 | Sale | $38.75 | 1,594 | 61,768 | 19,449 | Aug 31, 2017, 10:41 AM |
WALSH MATTHEW M | EVP & Chief Financial Officer | Aug 24, 2017 | Option Exercise | $35.21 | 8,245 | 290,306 | 103,703 | Aug 28, 2017, 12:29 PM |
Miyamoto Lance | SVP - Human Resources | Aug 24, 2017 | Option Exercise | $35.21 | 3,604 | 126,897 | 33,797 | Aug 28, 2017, 12:29 PM |
Maselli Alessandro | SVP - Global Operations | Aug 24, 2017 | Option Exercise | $35.21 | 718 | 25,281 | 13,603 | Aug 28, 2017, 12:29 PM |
Littlejohns Barry | President - DDS | Aug 24, 2017 | Option Exercise | $35.21 | 3,400 | 119,714 | 32,249 | Aug 28, 2017, 12:28 PM |
Joseph Wetteny | President - CSS | Aug 24, 2017 | Option Exercise | $35.21 | 1,822 | 64,153 | 14,277 | Aug 28, 2017, 12:28 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Aug 24, 2017 | Option Exercise | $35.21 | 869 | 30,597 | 11,870 | Aug 28, 2017, 12:28 PM |
Gennadios Aristippos | See Remarks | Aug 24, 2017 | Option Exercise | $35.21 | 2,633 | 92,708 | 22,525 | Aug 28, 2017, 12:27 PM |
Fasman Steven L | See Remarks | Aug 24, 2017 | Option Exercise | $35.21 | 3,828 | 134,784 | 37,666 | Aug 28, 2017, 12:27 PM |
Downie William | SVP, Global Sales & Marketing | Aug 24, 2017 | Option Exercise | $35.21 | 5,644 | 198,725 | 41,925 | Aug 28, 2017, 12:27 PM |
Dolan Christine | SVP - Product Development | Aug 24, 2017 | Option Exercise | $35.21 | 1,881 | 66,230 | 17,857 | Aug 28, 2017, 12:26 PM |
Chiminski John R | President & CEO | Aug 24, 2017 | Option Exercise | $35.21 | 19,472 | 685,609 | 355,724 | Aug 28, 2017, 12:26 PM |
Dolan Christine | SVP - Product Development | Aug 01, 2017 | Sale | $34.85 | 745 | 25,963 | 14,058 | Aug 03, 2017, 05:31 PM |
WALSH MATTHEW M | EVP & Chief Financial Officer | Jul 31, 2017 | Option Exercise | $34.97 | 3,230 | 112,953 | 95,757 | Aug 01, 2017, 06:35 PM |
Miyamoto Lance | SVP - Human Resources | Jul 31, 2017 | Option Exercise | $34.97 | 1,412 | 49,378 | 26,441 | Aug 01, 2017, 06:35 PM |
Maselli Alessandro | SVP - Global Operations | Jul 31, 2017 | Option Exercise | $34.97 | 703 | 24,584 | 12,802 | Aug 01, 2017, 06:35 PM |
Littlejohns Barry | President - DDS | Jul 31, 2017 | Option Exercise | $34.97 | 1,332 | 46,580 | 25,311 | Aug 01, 2017, 06:34 PM |
Joseph Wetteny | President - CSS | Jul 31, 2017 | Option Exercise | $34.97 | 712 | 24,899 | 10,558 | Aug 01, 2017, 06:34 PM |
Gunther Scott | SVP, Quality & Reg. Affairs | Jul 31, 2017 | Option Exercise | $34.97 | 845 | 29,550 | 10,098 | Aug 01, 2017, 06:34 PM |
Downie William | SVP, Global Sales & Marketing | Jul 31, 2017 | Option Exercise | $34.97 | 2,211 | 77,319 | 37,231 | Aug 01, 2017, 06:34 PM |
Dolan Christine | SVP - Product Development | Jul 31, 2017 | Option Exercise | $34.97 | 734 | 25,668 | 14,803 | Aug 01, 2017, 06:33 PM |
Chiminski John R | President & CEO | Jul 31, 2017 | Option Exercise | $34.97 | 3,816 | 133,446 | 321,274 | Aug 01, 2017, 06:33 PM |
WALSH MATTHEW M | See Remarks | Jun 08, 2017 | Option Exercise | $37.01 | 46,903 | 1,735,814 | 121,460 | Jun 12, 2017, 04:36 PM |
WALSH MATTHEW M | See Remarks | Jun 08, 2017 | Option Exercise | $11.84 | 74,651 | 884,064 | 168,363 | Jun 12, 2017, 04:36 PM |
Johnson Sharon | See Remarks | Apr 25, 2017 | Option Exercise | $29.00 | 52,392 | 1,519,368 | 32,929 | Apr 27, 2017, 11:02 AM |
Johnson Sharon | See Remarks | Apr 25, 2017 | Option Exercise | $14.82 | 70,716 | 1,047,668 | 53,670 | Apr 27, 2017, 11:02 AM |
Johnson Sharon | See Remarks | Apr 25, 2017 | Sale | $29.00 | 9,160 | 265,640 | 30,829 | Apr 27, 2017, 11:02 AM |
Downie William | See Remarks | Mar 20, 2017 | Option Exercise | $28.63 | 41,578 | 1,190,398 | 40,731 | Mar 22, 2017, 07:06 PM |
Downie William | See Remarks | Mar 20, 2017 | Option Exercise | $13.27 | 58,103 | 770,994 | 64,147 | Mar 22, 2017, 07:06 PM |
Downie William | See Remarks | Mar 20, 2017 | Sale | $28.60 | 8,262 | 236,293 | 36,665 | Mar 22, 2017, 07:06 PM |
Chiminski John R | See Remarks | Mar 16, 2017 | Option Exercise | $28.50 | 132,865 | 3,786,653 | 260,326 | Mar 20, 2017, 05:31 PM |
Chiminski John R | See Remarks | Mar 16, 2017 | Option Exercise | $10.71 | 206,684 | 2,213,586 | 393,191 | Mar 20, 2017, 05:31 PM |
Chiminski John R | See Remarks | Mar 16, 2017 | Sale | $28.62 | 73,618 | 2,106,756 | 191,492 | Mar 20, 2017, 05:31 PM |
Chiminski John R | See Remarks | Mar 20, 2017 | Sale | $28.76 | 201 | 5,781 | 186,507 | Mar 20, 2017, 05:31 PM |
MOREL DONALD E JR | Director | Feb 15, 2017 | Buy | $29.27 | 10,000 | 292,700 | 18,799 | Feb 16, 2017, 04:42 PM |
Blackstone Management Associates V L.L.C. | 10% Owner | Sep 09, 2016 | Sale | $23.58 | 17,100,705 | 403,234,623 | 0 | Sep 13, 2016, 06:07 PM |
Blackstone Management Associates V L.L.C. | 10% Owner | Jun 09, 2016 | Sale | $24.51 | 8,785,539 | 215,333,563 | 17,100,705 | Jun 13, 2016, 05:00 PM |
WALSH MATTHEW M | See Remarks | May 27, 2016 | Option Exercise | $28.85 | 67,927 | 1,959,694 | 101,443 | Jun 01, 2016, 05:35 PM |
WALSH MATTHEW M | See Remarks | May 27, 2016 | Option Exercise | $15.69 | 89,124 | 1,398,010 | 140,688 | Jun 01, 2016, 05:35 PM |
WALSH MATTHEW M | See Remarks | May 27, 2016 | Sale | $28.85 | 21,197 | 611,533 | 88,188 | Jun 01, 2016, 05:35 PM |
CARROLL J MARTIN | Director | Sep 04, 2015 | Option Exercise | $27.26 | 3,000 | 81,780 | 6,928 | Sep 09, 2015, 02:50 PM |
Chiminski John R | See Remarks | Aug 17, 2015 | Option Exercise | $33.80 | 61,495 | 2,078,531 | 378,623 | Aug 19, 2015, 06:02 PM |
Chiminski John R | See Remarks | Aug 17, 2015 | Option Exercise | $10.71 | 100,000 | 1,071,000 | 440,118 | Aug 19, 2015, 06:02 PM |
Chiminski John R | See Remarks | Aug 19, 2015 | Sale | $33.93 | 2,955 | 100,263 | 340,118 | Aug 19, 2015, 06:02 PM |
Chiminski John R | See Remarks | Aug 17, 2015 | Sale | $33.80 | 35,550 | 1,201,590 | 343,073 | Aug 19, 2015, 06:02 PM |
Chiminski John R | See Remarks | Aug 03, 2015 | Option Exercise | $33.85 | 64,723 | 2,190,873 | 375,395 | Aug 05, 2015, 04:28 PM |
Chiminski John R | See Remarks | Aug 03, 2015 | Option Exercise | $10.71 | 100,000 | 1,071,000 | 440,118 | Aug 05, 2015, 04:28 PM |
Chiminski John R | See Remarks | Aug 03, 2015 | Sale | $33.85 | 35,277 | 1,194,126 | 340,118 | Aug 05, 2015, 04:28 PM |
WALSH MATTHEW M | See Remarks | Jul 27, 2015 | Option Exercise | $30.50 | 57,545 | 1,755,123 | 99,740 | Jul 29, 2015, 01:58 PM |
WALSH MATTHEW M | See Remarks | Jul 27, 2015 | Option Exercise | $11.50 | 84,717 | 974,229 | 130,880 | Jul 29, 2015, 01:58 PM |
WALSH MATTHEW M | See Remarks | Jul 27, 2015 | Sale | $31.18 | 27,172 | 847,223 | 84,120 | Jul 29, 2015, 01:58 PM |
Chiminski John R | See Remarks | Jul 20, 2015 | Option Exercise | $29.40 | 66,919 | 1,967,419 | 359,140 | Jul 22, 2015, 01:54 PM |
Chiminski John R | See Remarks | Jul 20, 2015 | Option Exercise | $10.71 | 100,000 | 1,071,000 | 397,618 | Jul 22, 2015, 01:54 PM |
Chiminski John R | See Remarks | Jul 20, 2015 | Sale | $29.40 | 33,081 | 972,581 | 340,118 | Jul 22, 2015, 01:54 PM |
Chiminski John R | See Remarks | Jul 06, 2015 | Option Exercise | $29.34 | 66,172 | 1,941,486 | 373,946 | Jul 08, 2015, 08:42 AM |
Chiminski John R | See Remarks | Jul 06, 2015 | Option Exercise | $10.71 | 100,000 | 1,071,000 | 440,118 | Jul 08, 2015, 08:42 AM |
Chiminski John R | See Remarks | Jul 06, 2015 | Sale | $29.34 | 33,828 | 992,514 | 340,118 | Jul 08, 2015, 08:42 AM |
Blackstone Management Associates V L.L.C. | 10% Owner | Jun 11, 2015 | Sale | $28.13 | 1,844,963 | 51,898,808 | 25,886,244 | Jun 11, 2015, 05:00 PM |
Blackstone Management Associates V L.L.C. | 10% Owner | Jun 08, 2015 | Sale | $28.13 | 12,299,753 | 345,992,042 | 27,731,207 | Jun 10, 2015, 05:00 PM |
WALSH MATTHEW M | See Remarks | Apr 06, 2015 | Option Exercise | $30.43 | 67,987 | 2,068,844 | 116,559 | Apr 08, 2015, 11:08 AM |
WALSH MATTHEW M | See Remarks | Apr 06, 2015 | Option Exercise | $10.71 | 102,043 | 1,092,881 | 184,546 | Apr 08, 2015, 11:08 AM |
WALSH MATTHEW M | See Remarks | Apr 06, 2015 | Sale | $30.43 | 34,439 | 1,047,979 | 84,120 | Apr 08, 2015, 11:08 AM |
Houlton Scott | See Remarks | Apr 01, 2015 | Option Exercise | $30.61 | 65,936 | 2,018,301 | 37,973 | Apr 03, 2015, 05:29 PM |
Houlton Scott | See Remarks | Apr 01, 2015 | Option Exercise | $11.98 | 98,035 | 1,174,870 | 74,571 | Apr 03, 2015, 05:29 PM |
Houlton Scott | See Remarks | Apr 01, 2015 | Sale | $30.61 | 16,253 | 497,504 | 34,127 | Apr 03, 2015, 05:29 PM |
Gennadios Aristippos | See Remarks | Apr 01, 2015 | Option Exercise | $30.61 | 39,861 | 1,220,145 | 21,734 | Apr 03, 2015, 05:00 PM |
Gennadios Aristippos | See Remarks | Apr 01, 2015 | Option Exercise | $11.22 | 65,464 | 734,573 | 38,961 | Apr 03, 2015, 05:00 PM |
Gennadios Aristippos | See Remarks | Apr 01, 2015 | Sale | $30.61 | 24,868 | 761,209 | 8,651 | Apr 03, 2015, 05:00 PM |
WALSH MATTHEW M | See Remarks | Mar 27, 2015 | Option Exercise | $30.10 | 11,039 | 332,274 | 84,503 | Mar 31, 2015, 06:23 PM |
Leonard Stephen | See Remarks | Mar 27, 2015 | Option Exercise | $30.13 | 83,714 | 2,522,303 | 75,536 | Mar 31, 2015, 06:11 PM |
Leonard Stephen | See Remarks | Mar 27, 2015 | Option Exercise | $10.71 | 136,000 | 1,456,560 | 159,250 | Mar 31, 2015, 06:11 PM |
Leonard Stephen | See Remarks | Mar 27, 2015 | Sale | $30.13 | 31,005 | 934,181 | 44,531 | Mar 31, 2015, 06:11 PM |
Johnson Sharon | See Remarks | Feb 17, 2015 | Option Exercise | $27.40 | 53,169 | 1,456,831 | 39,596 | Feb 19, 2015, 08:14 PM |
Johnson Sharon | See Remarks | Feb 13, 2015 | Option Exercise | $27.83 | 33,300 | 926,739 | 25,523 | Feb 19, 2015, 08:14 PM |
Johnson Sharon | See Remarks | Feb 17, 2015 | Option Exercise | $11.00 | 77,852 | 856,691 | 90,383 | Feb 19, 2015, 08:14 PM |
Johnson Sharon | See Remarks | Feb 13, 2015 | Option Exercise | $10.71 | 49,400 | 529,074 | 46,473 | Feb 19, 2015, 08:14 PM |
Johnson Sharon | See Remarks | Feb 13, 2015 | Sale | $27.82 | 16,100 | 447,962 | 15,393 | Feb 19, 2015, 08:14 PM |
Johnson Sharon | See Remarks | Feb 17, 2015 | Sale | $27.40 | 24,683 | 676,314 | 15,393 | Feb 19, 2015, 08:14 PM |
Kurt Nielsen | See Remarks | Feb 17, 2015 | Option Exercise | $27.41 | 42,429 | 1,162,979 | 52,767 | Feb 19, 2015, 07:28 PM |
Kurt Nielsen | See Remarks | Feb 17, 2015 | Option Exercise | $10.71 | 71,520 | 765,979 | 95,196 | Feb 19, 2015, 07:28 PM |
Kurt Nielsen | See Remarks | Feb 17, 2015 | Sale | $27.41 | 29,091 | 797,384 | 23,676 | Feb 19, 2015, 07:28 PM |
Kurt Nielsen | See Remarks | Feb 17, 2015 | Option Exercise | $27.41 | 28,040 | 768,576 | 43,676 | Feb 19, 2015, 09:39 AM |
Kurt Nielsen | See Remarks | Feb 17, 2015 | Option Exercise | $10.71 | 48,040 | 514,508 | 71,716 | Feb 19, 2015, 09:39 AM |
Kurt Nielsen | See Remarks | Feb 17, 2015 | Sale | $27.41 | 20,000 | 548,200 | 23,676 | Feb 19, 2015, 09:39 AM |
Houlton Scott | See Remarks | Feb 13, 2015 | Option Exercise | $28.28 | 1,893 | 53,534 | 20 | Feb 18, 2015, 09:28 PM |
Houlton Scott | See Remarks | Feb 17, 2015 | Option Exercise | $27.42 | 18 | 494 | 31,419 | Feb 18, 2015, 09:28 PM |
Houlton Scott | See Remarks | Feb 17, 2015 | Option Exercise | $10.71 | 31,210 | 334,259 | 49,491 | Feb 18, 2015, 09:28 PM |
Houlton Scott | See Remarks | Feb 13, 2015 | Option Exercise | $10.71 | 3,293 | 35,268 | 21,574 | Feb 18, 2015, 09:28 PM |
Houlton Scott | See Remarks | Feb 13, 2015 | Sale | $28.28 | 1,400 | 39,592 | 18,281 | Feb 18, 2015, 09:28 PM |
Houlton Scott | See Remarks | Feb 17, 2015 | Sale | $27.42 | 13,138 | 360,244 | 18,281 | Feb 18, 2015, 09:28 PM |
Leonard Stephen | See Remarks | Feb 13, 2015 | Option Exercise | $28.34 | 1,508 | 42,737 | 24,250 | Feb 18, 2015, 09:01 PM |
Leonard Stephen | See Remarks | Feb 13, 2015 | Option Exercise | $10.71 | 2,508 | 26,861 | 25,758 | Feb 18, 2015, 09:01 PM |
Leonard Stephen | See Remarks | Feb 13, 2015 | Sale | $28.34 | 1,000 | 28,340 | 23,250 | Feb 18, 2015, 09:01 PM |
Downie William | See Remarks | Feb 13, 2015 | Option Exercise | $27.86 | 5,122 | 142,699 | 23,351 | Feb 18, 2015, 08:39 PM |
Downie William | See Remarks | Feb 17, 2015 | Option Exercise | $27.82 | 93,969 | 2,614,218 | 55,866 | Feb 18, 2015, 08:39 PM |
Downie William | See Remarks | Feb 13, 2015 | Option Exercise | $10.71 | 6,202 | 66,423 | 28,473 | Feb 18, 2015, 08:39 PM |
Downie William | See Remarks | Feb 17, 2015 | Option Exercise | $10.71 | 138,969 | 1,488,358 | 126,240 | Feb 18, 2015, 08:39 PM |
Downie William | See Remarks | Feb 13, 2015 | Sale | $27.86 | 1,080 | 30,089 | 22,271 | Feb 18, 2015, 08:39 PM |
Downie William | See Remarks | Feb 17, 2015 | Sale | $27.82 | 45,000 | 1,251,900 | 22,271 | Feb 18, 2015, 08:39 PM |
WALSH MATTHEW M | See Remarks | Feb 13, 2015 | Sale | $28.11 | 3,200 | 89,952 | 95,542 | Feb 18, 2015, 06:50 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Hopson Ricky | Pres. BioProduct Delivery, CoS | 08/02/2024 | 39,429 |
Gunther Scott | SVP, Quality & Reg. Affairs | 08/02/2024 | 39,660 |
Ferraro Joseph Anthony | SVP, General Counsel, CCO | 08/02/2024 | 36,225 |
Evoli Lisa | SVP, Chief HR Officer | 08/02/2024 | 230,267 |
Gennadios Aristippos | Group Pres. Pharma & Consumer | 08/02/2024 | 69,614 |
Maselli Alessandro | President & CEO | 07/29/2024 | 534,011 |
Hopson Ricky | Pres. BioProduct Delivery, CoS | 07/29/2024 | 12,086 |
Gunther Scott | SVP, Quality & Reg. Affairs | 07/29/2024 | 16,609 |
Gennadios Aristippos | Group Pres. Pharma & Consumer | 07/29/2024 | 20,486 |
Masanovich Matti | SVP, Chief Financial Officer | 07/08/2024 | 169,823 |
Hopson Ricky | Pres. BioProduct Delivery, CoS | 06/04/2024 | 76,023 |
Gunther Scott | SVP, Quality & Reg. Affairs | 03/15/2024 | 21,749 |
Kreuzburg Christa | Director | 01/25/2024 | 26,364 |
Gennadios Aristippos | Group Pres. Pharma & Consumer | 12/08/2023 | 13,645 |
Maselli Alessandro | President & CEO | 12/08/2023 | 71,534 |
Gunther Scott | SVP, Quality & Reg. Affairs | 12/08/2023 | 9,295 |
Hopson Ricky | Pres. Clinical Dev Supply Div | 12/08/2023 | 9,518 |
Kreuzburg Christa | Director | 10/27/2023 | 48,953 |
Hunt Patricia | Pres. Consumer Health Div | 10/16/2023 | 1,023 |
Ryan Michelle R | Director | 08/31/2023 | 49,980 |
GREISCH JOHN J | Executive Chair | 08/30/2023 | 1,055,040 |
Maselli Alessandro | President & CEO | 08/24/2023 | 92,245 |
Gunther Scott | SVP, Quality & Reg. Affairs | 08/24/2023 | 11,989 |
Grippo Michael J | SVP, Strategy & Corp. Dev. | 08/24/2023 | 17,355 |
Gennadios Aristippos | Group Pres. Pharma & Consumer | 08/24/2023 | 17,618 |
Fasman Steven L | EVP & Chief Admin Officer | 08/24/2023 | 36,479 |
Carletti Lorenzo | SVP Global Ops Ph & Cons Hlth | 08/24/2023 | 9,657 |
Arnold Jonathan | SVP, CCO & Div. Head BioP Del. | 08/24/2023 | 3,904 |
Hopson Ricky | Pres. Clinical Dev Supply Div | 08/24/2023 | 12,299 |
Hawkeswood Thomas W | Pres. Pharma Prod Delivery Div | 08/24/2023 | 6,574 |
Lickfold Charles | SVP, CIO | 08/24/2023 | 8,497 |
Hunt Patricia | Pres. Consumer Health Div | 08/24/2023 | 4,746 |
Pravda Ricardo | Chief Transformation Officer | 08/24/2023 | 16,854 |
Pravda Ricardo | Chief Transformation Officer | 08/01/2023 | 12,793 |
Maselli Alessandro | President & CEO | 08/01/2023 | 69,995 |
Lickfold Charles | SVP, CIO | 08/01/2023 | 6,467 |
Hunt Patricia | Pres. Consumer Health Div | 08/01/2023 | 7,720 |
Hopson Ricky | Pres. Clinical Dev Supply Div | 08/01/2023 | 9,333 |
Hawkeswood Thomas W | Pres. Pharma Prod Delivery Div | 08/01/2023 | 12,376 |
Gunther Scott | SVP, Quality & Reg. Affairs | 08/01/2023 | 9,101 |
Grippo Michael J | SVP, Strategy & Corp. Dev. | 08/01/2023 | 13,171 |
Gennadios Aristippos | Group Pres. Pharma & Consumer | 08/01/2023 | 13,373 |
Carletti Lorenzo | SVP Global Ops Ph & Cons Hlth | 08/01/2023 | 18,296 |
Arnold Jonathan | SVP, CCO & Div. Head BioP Del. | 08/01/2023 | 2,964 |
Fasman Steven L | EVP & Chief Admin Officer | 08/01/2023 | 77,026 |
Boerman Manja | Pres. BioModalities Division | 05/01/2023 | 72,098 |
Gargiulo Mario | SVP, Ops, Biologics Europe | 05/01/2023 | 33,805 |
Hopson Ricky | Pres. Clinical Dev Supply Div | 01/23/2023 | 31,738 |
Boerman Manja | Pres. BioModalities Division | 12/05/2022 | 40,326 |
Grippo Michael J | SVP, Strategy & Corp. Dev. | 10/31/2022 | 161,349 |
Kreuzburg Christa | Director | 10/27/2022 | 27,900 |
Hawkeswood Thomas W | Pres. Pharma Prod Delivery Div | 10/10/2022 | 72,038 |
Hopson Ricky | Pres. Clinical Dev Supply Div | 08/31/2022 | 198,531 |
Riley Michael A. | Pres. Bio Product Delivery Div | 08/26/2022 | 259,238 |
Gunther Scott | SVP, Quality & Reg. Affairs | 08/26/2022 | 170,571 |
Schmidt Kay A | SVP, Enterprise Functions | 08/25/2022 | 136,116 |
Riley Michael A. | Pres. Bio Product Delivery Div | 08/25/2022 | 152,705 |
Pravda Ricardo | SVP & Chief HR Officer | 08/25/2022 | 180,011 |
Maselli Alessandro | President & CEO | 08/25/2022 | 478,724 |
Hunt Patricia | Pres. Consumer Health Div | 08/25/2022 | 34,931 |
Hopson Ricky | Pres. Clinical Dev Supply Div | 08/25/2022 | 156,312 |
Hawkeswood Thomas W | Pres. Pharma Prod Delivery Div | 08/25/2022 | 69,140 |
Gunther Scott | SVP, Quality & Reg. Affairs | 08/25/2022 | 189,594 |
Grippo Michael J | SVP, Strategy & Corp. Dev. | 08/25/2022 | 172,077 |
Gennadios Aristippos | Group Pres. Pharma & Consumer | 08/25/2022 | 169,501 |
Gargiulo Mario | SVP Global Ops Biologics | 08/25/2022 | 163,421 |
Fasman Steven L | EVP & Chief Admin Officer | 08/25/2022 | 495,725 |
Chiminski John R | Executive Chair | 08/25/2022 | 4,011,759 |
Castellano Thomas P | SVP, Chief Financial Officer | 08/25/2022 | 145,699 |
Carletti Lorenzo | SVP Global Ops Ph & Cons Hlth | 08/25/2022 | 106,440 |
Boerman Manja | Pres. BioModalities Division | 08/25/2022 | 339,620 |
Arnold Jonathan | SVP & Chief Commercial Ofcr | 08/25/2022 | 39,567 |
Schmidt Kay A | SVP, Enterprise Functions | 07/26/2022 | 34,529 |
Pravda Ricardo | SVP & Chief HR Officer | 07/26/2022 | 45,646 |
Maselli Alessandro | President & CEO | 07/26/2022 | 87,230 |
Hopson Ricky | Pres, Clinical Dev & Supply | 07/27/2022 | 63,633 |
Hopson Ricky | Pres, Clinical Dev & Supply | 07/26/2022 | 33,353 |
Gunther Scott | SVP, Quality & Reg. Affairs | 07/27/2022 | 42,422 |
Gunther Scott | SVP, Quality & Reg. Affairs | 07/26/2022 | 48,105 |
Grippo Michael J | SVP, Strategy & Corp. Dev. | 07/27/2022 | 41,776 |
Grippo Michael J | SVP, Strategy & Corp. Dev. | 07/26/2022 | 43,722 |
Gennadios Aristippos | Group Pres. Pharma & Consumer | 07/26/2022 | 43,081 |
Gargiulo Mario | SVP Global Ops Biologics | 07/26/2022 | 103,586 |
Fasman Steven L | EVP & Chief Admin Officer | 07/26/2022 | 272,167 |
Chiminski John R | Executive Chair | 07/26/2022 | 1,035,968 |
Castellano Thomas P | SVP, Chief Financial Officer | 07/26/2022 | 37,094 |
Carletti Lorenzo | SVP Global Ops Ph & Cons Hlth | 07/26/2022 | 67,454 |
Arnold Jonathan | SVP & Chief Commercial Ofcr | 07/26/2022 | 10,049 |
Gennadios Aristippos | Group Pres. Pharma & Consumer | 07/01/2022 | 2,000,097 |
Arnold Jonathan | SVP & Chief Commercial Ofcr | 07/01/2022 | 300,084 |
Gargiulo Mario | SVP Global Ops Large Molecule | 06/10/2022 | 12,578 |
Fasman Steven L | SVP & General Counsel | 06/10/2022 | 535,352 |
Zippelius Peter | Director | 02/06/2022 | 49,999,995 |
Hopson Ricky | VP, Chief Accounting Officer | 01/31/2022 | 240,382 |
Whitlow Ricci S | President, CSS | 01/21/2022 | 18,836 |
Flynn Karen | Chief Commercial Officer | 01/10/2022 | 288,334 |
Zippelius Peter | Director | 11/18/2021 | 387,555,795 |
Zippelius Peter | Director | 11/30/2021 | 387,900,009 |
CARROLL J MARTIN | Director | 11/29/2021 | 420,600 |
CARROLL J MARTIN | Director | 11/29/2021 | 420,600 |
LUCIER GREGORY T | Director | 11/23/2021 | 645,407 |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | 11/01/2021 | 338,421 |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | 11/01/2021 | 1,494,293 |
Kreuzburg Christa | Director | 10/28/2021 | 86,449 |
Castellano Thomas P | SVP, Chief Financial Officer | 10/20/2021 | 309,138 |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | 10/14/2021 | 214,950 |
Schmidt Kay A | SVP, Technical Operations | 10/04/2021 | 287,569 |
Fasman Steven L | SVP & General Counsel | 10/04/2021 | 889,050 |
Fasman Steven L | SVP & General Counsel | 10/04/2021 | 4,479,975 |
Pravda Ricardo | SVP & Chief HR Officer | 10/01/2021 | 241,694 |
Pravda Ricardo | SVP & Chief HR Officer | 10/01/2021 | 650,928 |
Grippo Michael J | SVP, Strategy & Corp. Dev. | 10/01/2021 | 270,557 |
Chiminski John R | Chair & CEO | 10/01/2021 | 2,986,973 |
Chiminski John R | Chair & CEO | 10/01/2021 | 19,979,610 |
Kreuzburg Christa | Director | 08/27/2021 | 25,840 |
Castellano Thomas P | SVP, Chief Financial Officer | 08/27/2021 | 274,458 |
Schmidt Kay A | SVP, Technical Operations | 08/27/2021 | 108,183 |
Hopson Ricky | VP, Chief Accounting Officer | 08/27/2021 | 192,894 |
Pravda Ricardo | SVP & Chief HR Officer | 08/27/2021 | 90,742 |
Maselli Alessandro | President & COO | 08/27/2021 | 490,824 |
Gunther Scott | SVP, Quality & Reg. Affairs | 08/27/2021 | 545,725 |
Grippo Michael J | SVP, Strategy & Corp. Dev. | 08/27/2021 | 222,661 |
Gennadios Aristippos | President Softgel & Oral Tech | 08/27/2021 | 296,619 |
Fasman Steven L | SVP & General Counsel | 08/27/2021 | 801,344 |
Chiminski John R | Chair & CEO | 08/27/2021 | 5,830,710 |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | 08/27/2021 | 59,271 |
Grippo Michael J | SVP, Strategy & Corp. Dev. | 12/19/2019 | 99,684 |
Grippo Michael J | SVP, Strategy & Corp. Dev. | 01/13/2020 | 97,440 |
Grippo Michael J | SVP, Strategy & Corp. Dev. | 12/20/2019 | 134,736 |
Castellano Thomas P | SVP, Chief Financial Officer | 07/26/2021 | 62,743 |
Schmidt Kay A | SVP, Technical Operations | 07/26/2021 | 61,838 |
Hopson Ricky | VP, Chief Accounting Officer | 07/26/2021 | 40,698 |
Pravda Ricardo | SVP & Chief HR Officer | 07/26/2021 | 51,777 |
Maselli Alessandro | President & COO | 07/26/2021 | 112,259 |
Gunther Scott | SVP, Quality & Reg. Affairs | 07/26/2021 | 121,967 |
Grippo Michael J | SVP, Strategy & Corp. Dev. | 07/26/2021 | 50,986 |
Gennadios Aristippos | President Softgel & Oral Tech | 07/26/2021 | 52,568 |
Fasman Steven L | SVP & General Counsel | 07/26/2021 | 175,114 |
Chiminski John R | Chair & CEO | 07/26/2021 | 1,259,038 |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | 07/26/2021 | 13,566 |
Fasman Steven L | SVP & General Counsel | 07/15/2021 | 494,353 |
Pravda Ricardo | SVP & Chief HR Officer | 06/23/2021 | 309,624 |
Schmidt Kay A | SVP, Technical Operations | 03/22/2021 | 148,078 |
Fasman Steven L | SVP & General Counsel | 03/18/2021 | 839,445 |
Fasman Steven L | SVP & General Counsel | 03/18/2021 | 2,262,770 |
Chiminski John R | Chair & CEO | 03/19/2021 | 7,698,674 |
Chiminski John R | Chair & CEO | 03/18/2021 | 1,520,764 |
Chiminski John R | Chair & CEO | 03/19/2021 | 19,402,784 |
Chiminski John R | Chair & CEO | 03/18/2021 | 4,439,855 |
Joseph Wetteny | SVP & Chief Financial Officer | 02/16/2021 | 262,799 |
Joseph Wetteny | SVP & Chief Financial Officer | 02/16/2021 | 622,685 |
Joseph Wetteny | SVP & Chief Financial Officer | 02/08/2021 | 523,613 |
Whitlow Ricci S | President, CSS | 01/21/2021 | 82,244 |
Flynn Karen | Pres. Biologics & CCO | 01/11/2021 | 278,279 |
Gunther Scott | SVP, Quality & Reg. Affairs | 01/06/2021 | 6,392 |
Whitlow Ricci S | President, CSS | 01/04/2021 | 8,667 |
Schmidt Kay A | SVP, Technical Operations | 01/04/2021 | 7,623 |
Pravda Ricardo | SVP & Chief HR Officer | 01/04/2021 | 8,145 |
Maselli Alessandro | President & COO | 01/04/2021 | 15,454 |
Joseph Wetteny | SVP & Chief Financial Officer | 01/04/2021 | 17,960 |
Gunther Scott | SVP, Quality & Reg. Affairs | 01/04/2021 | 12,530 |
Grippo Michael J | SVP, Strategy & Corp. Dev. | 01/04/2021 | 13,157 |
Gennadios Aristippos | President Softgel & Oral Tech | 01/04/2021 | 11,486 |
Flynn Karen | Pres. Biologics & CCO | 01/04/2021 | 10,338 |
Fasman Steven L | SVP & General Counsel | 01/04/2021 | 19,735 |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | 01/04/2021 | 1,671 |
Gennadios Aristippos | President Softgel & Oral Tech | 12/21/2020 | 446,526 |
Gennadios Aristippos | President Softgel & Oral Tech | 12/21/2020 | 1,405,044 |
Zippelius Peter | Director | 11/23/2020 | 267,138,411 |
Zippelius Peter | Director | 11/23/2020 | 535,237,724 |
Fasman Steven L | SVP & General Counsel | 11/11/2020 | 244,901 |
Schmidt Kay A | SVP, Technical Operations | 10/23/2020 | 39,958 |
Schmidt Kay A | SVP, Technical Operations | 10/14/2020 | 278,045 |
Fasman Steven L | SVP & General Counsel | 10/14/2020 | 885,883 |
Fasman Steven L | SVP & General Counsel | 10/14/2020 | 393,426 |
Fasman Steven L | SVP & General Counsel | 10/14/2020 | 512,934 |
Grippo Michael J | SVP, Strategy & Corp. Dev. | 10/12/2020 | 159,583 |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | 10/07/2020 | 2,142,381 |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | 10/07/2020 | 1,213,364 |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | 10/07/2020 | 1,457,412 |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | 10/04/2020 | 20,611 |
Gunther Scott | SVP, Quality & Reg. Affairs | 10/02/2020 | 441,688 |
Gunther Scott | SVP, Quality & Reg. Affairs | 10/02/2020 | 264,639 |
Gunther Scott | SVP, Quality & Reg. Affairs | 10/02/2020 | 372,608 |
Chiminski John R | Chair & CEO | 10/02/2020 | 7,418,449 |
Chiminski John R | Chair & CEO | 10/02/2020 | 4,130,817 |
Chiminski John R | Chair & CEO | 10/02/2020 | 15,673,809 |
Grippo Michael J | SVP, Strategy & Corp. Dev. | 09/02/2020 | 201,378 |
Schmidt Kay A | SVP, Technical Operations | 08/27/2020 | 79,290 |
Pravda Ricardo | SVP & Chief HR Officer | 08/27/2020 | 82,711 |
Maselli Alessandro | President & COO | 08/27/2020 | 369,873 |
Joseph Wetteny | SVP & Chief Financial Officer | 08/27/2020 | 305,231 |
Gunther Scott | SVP, Quality & Reg. Affairs | 08/27/2020 | 247,605 |
Grippo Michael J | SVP, Strategy & Corp. Dev. | 08/27/2020 | 209,802 |
Gennadios Aristippos | President Softgel & Oral Tech | 08/27/2020 | 384,521 |
Fasman Steven L | SVP & General Counsel | 08/27/2020 | 585,552 |
Chiminski John R | Chair & CEO | 08/27/2020 | 5,172,960 |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | 08/27/2020 | 265,147 |
Kreuzburg Christa | Director | 08/22/2020 | 82,252 |
Chiminski John R | Chair & CEO | 08/23/2020 | 402,092 |
LUCIER GREGORY T | Director | 07/30/2020 | 2,162,160 |
Schmidt Kay A | SVP, Technical Operations | 07/24/2020 | 41,147 |
Pravda Ricardo | SVP & Chief HR Officer | 07/24/2020 | 159,116 |
Maselli Alessandro | President & COO | 07/24/2020 | 76,742 |
Joseph Wetteny | SVP & Chief Financial Officer | 07/24/2020 | 62,128 |
Gunther Scott | SVP, Quality & Reg. Affairs | 07/24/2020 | 52,739 |
Grippo Michael J | SVP, Strategy & Corp. Dev. | 07/24/2020 | 43,432 |
Gennadios Aristippos | President Softgel & Oral Tech | 07/24/2020 | 80,334 |
Fasman Steven L | SVP & General Counsel | 07/24/2020 | 100,172 |
Chiminski John R | Chair & CEO | 07/24/2020 | 542,253 |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | 07/24/2020 | 309,905 |
Gunther Scott | SVP, Quality & Reg. Affairs | 06/29/2020 | 203,318 |
Gennadios Aristippos | President Softgel & Oral Tech | 06/25/2020 | 1,016,890 |
Gennadios Aristippos | President Softgel & Oral Tech | 06/25/2020 | 622,541 |
Gennadios Aristippos | President Softgel & Oral Tech | 06/25/2020 | 607,725 |
CARROLL J MARTIN | Director | 05/12/2020 | 260,244 |
CARROLL J MARTIN | Director | 05/12/2020 | 260,244 |
Whitlow Ricci S | President, CSS | 04/09/2020 | 13,550 |
Schmidt Kay A | SVP, Technical Operations | 04/09/2020 | 12,760 |
Pravda Ricardo | SVP & Chief HR Officer | 04/09/2020 | 12,760 |
Maselli Alessandro | President & COO | 04/09/2020 | 17,785 |
Joseph Wetteny | SVP & Chief Financial Officer | 04/09/2020 | 19,705 |
Gunther Scott | SVP, Quality & Reg. Affairs | 04/09/2020 | 13,720 |
Grippo Michael J | SVP, Strategy & Corp. Dev. | 04/09/2020 | 14,454 |
Gennadios Aristippos | President Softgel & Oral Tech | 04/09/2020 | 15,752 |
Flynn Karen | Pres. Biologics & CCO | 04/09/2020 | 20,269 |
Fasman Steven L | SVP & General Counsel | 04/09/2020 | 21,794 |
BUZY PETER L | President, Gene Therapy | 04/09/2020 | 15,018 |
Arnold Jonathan | Pres. Oral & Specialty Deliv. | 04/09/2020 | 14,905 |
LUCIER GREGORY T | Director | 02/13/2020 | 119,420 |
Schmidt Kay A | SVP, Technical Operations | 02/02/2020 | 12,648 |
Maselli Alessandro | President & COO | 12/16/2019 | 386,512 |
Pravda Ricardo | SVP & Chief HR Officer | 11/26/2019 | 137,718 |
Gennadios Aristippos | President Softgel & Oral Tech | 11/25/2019 | 4,131,218 |
Gennadios Aristippos | President Softgel & Oral Tech | 11/25/2019 | 2,272,760 |
Gennadios Aristippos | President Softgel & Oral Tech | 11/25/2019 | 2,378,203 |
Grippo Michael J | SVP, Strategy & Corp. Dev. | 11/22/2019 | 19,552 |
Chiminski John R | Chair & CEO | 10/07/2019 | 1,664,907 |
Chiminski John R | Chair & CEO | 10/07/2019 | 1,160,409 |
Chiminski John R | Chair & CEO | 10/07/2019 | 4,739,580 |
LUCIER GREGORY T | Director | 09/09/2019 | 103,280 |
Maselli Alessandro | President & COO | 09/09/2019 | 173,132 |
Schmidt Kay A | SVP, Technical Operations | 08/22/2019 | 63,692 |
Pravda Ricardo | SVP, Human Resources | 08/22/2019 | 67,282 |
Maselli Alessandro | President & COO | 08/22/2019 | 301,942 |
Littlejohns Barry | President, Biologics & SDD | 08/22/2019 | 396,513 |
Kreuzburg Christa | Director | 08/23/2019 | 66,703 |
Joseph Wetteny | SVP & Chief Financial Officer | 08/22/2019 | 230,682 |
HEGWOOD PAUL W JR | President, CSS | 08/22/2019 | 59,052 |
Gunther Scott | SVP, Quality & Reg. Affairs | 08/22/2019 | 72,751 |
Gennadios Aristippos | President, Softgel Tech. | 08/22/2019 | 210,188 |
Fasman Steven L | SVP & General Counsel | 08/22/2019 | 492,796 |
Chiminski John R | Chair & CEO | 08/22/2019 | 2,859,609 |
Arnold Jonathan | President, Oral Drug Delivery | 08/22/2019 | 152,739 |
Schmidt Kay A | SVP, Technical Operations | 07/26/2019 | 61,784 |
Pravda Ricardo | SVP, Human Resources | 07/26/2019 | 85,775 |
Maselli Alessandro | President & COO | 07/26/2019 | 56,344 |
Littlejohns Barry | President, Biologics & SDD | 07/26/2019 | 70,659 |
Joseph Wetteny | SVP & Chief Financial Officer | 07/26/2019 | 54,626 |
HEGWOOD PAUL W JR | President, CSS | 07/26/2019 | 75,469 |
Gunther Scott | SVP, Quality & Reg. Affairs | 07/26/2019 | 93,105 |
Gennadios Aristippos | President, Softgel Tech. | 07/26/2019 | 42,830 |
Fasman Steven L | SVP & General Counsel | 07/26/2019 | 126,258 |
Chiminski John R | Chair & CEO | 07/26/2019 | 763,448 |
Arnold Jonathan | President, Oral Drug Delivery | 07/26/2019 | 137,080 |
CARROLL J MARTIN | Director | 07/15/2019 | 262,313 |
CARROLL J MARTIN | Director | 07/15/2019 | 262,313 |
Littlejohns Barry | President, Biologics & SDD | 07/12/2019 | 1,781,383 |
Littlejohns Barry | President, Biologics & SDD | 07/12/2019 | 952,938 |
Littlejohns Barry | President, Biologics & SDD | 07/12/2019 | 853,344 |
Fasman Steven L | SVP & General Counsel | 07/11/2019 | 1,028,350 |
Fasman Steven L | SVP & General Counsel | 07/11/2019 | 741,142 |
Fasman Steven L | SVP & General Counsel | 07/11/2019 | 219,024 |
BUZY PETER L | President, Gene Therapy | 05/29/2019 | 2,008,285 |
Joseph Wetteny | SVP & Chief Financial Officer | 05/28/2019 | 216,218 |
Joseph Wetteny | SVP & Chief Financial Officer | 05/28/2019 | 101,242 |
MOREL DONALD E JR | Director | 05/15/2019 | 444,400 |
LUCIER GREGORY T | Director | 05/09/2019 | 90,160 |
Gennadios Aristippos | President, Softgel Tech. | 03/21/2019 | 284,385 |
Gennadios Aristippos | President, Softgel Tech. | 03/21/2019 | 144,885 |
Gennadios Aristippos | President, Softgel Tech. | 03/21/2019 | 143,089 |
Miyamoto Lance | SVP, Human Resources | 03/07/2019 | 3,410,816 |
Miyamoto Lance | SVP, Human Resources | 03/07/2019 | 1,896,336 |
Miyamoto Lance | SVP, Human Resources | 03/07/2019 | 1,853,379 |
Kreuzburg Christa | Director | 02/16/2019 | 15,047 |
Downie William | SVP, Global Sales & Marketing | 02/15/2019 | 408,912 |
Downie William | SVP, Global Sales & Marketing | 02/15/2019 | 307,505 |
Downie William | SVP, Global Sales & Marketing | 02/15/2019 | 307,230 |
Fasman Steven L | SVP & General Counsel | 01/28/2019 | 189,712 |
GREISCH JOHN J | Director | 11/08/2018 | 488,930 |
Miyamoto Lance | SVP, Human Resources | 10/16/2018 | 487,688 |
Miyamoto Lance | SVP, Human Resources | 10/16/2018 | 218,520 |
Miyamoto Lance | SVP, Human Resources | 10/16/2018 | 277,313 |
Littlejohns Barry | President, Biologics & SDD | 10/15/2018 | 4,061,815 |
Littlejohns Barry | President, Biologics & SDD | 10/15/2018 | 2,151,891 |
Littlejohns Barry | President, Biologics & SDD | 10/15/2018 | 1,968,115 |
Joseph Wetteny | SVP & Chief Financial Officer | 10/15/2018 | 12,565 |
Chiminski John R | Chair, President & CEO | 10/01/2018 | 9,046,234 |
Chiminski John R | Chair, President & CEO | 10/01/2018 | 6,027,735 |
Chiminski John R | Chair, President & CEO | 10/01/2018 | 5,916,299 |
MOREL DONALD E JR | Director | 09/13/2018 | 430,000 |
Miyamoto Lance | SVP, Human Resources | 08/27/2018 | 43,092 |
Maselli Alessandro | SVP, Global Operations | 08/27/2018 | 18,643 |
Littlejohns Barry | President, Biologics & SDD | 08/27/2018 | 41,215 |
Joseph Wetteny | SVP & Chief Financial Officer | 08/27/2018 | 21,917 |
HEGWOOD PAUL W JR | President, CSS | 08/27/2018 | 22,048 |
Gunther Scott | SVP, Quality & Reg. Affairs | 08/27/2018 | 25,759 |
Fasman Steven L | SVP & General Counsel | 08/27/2018 | 46,411 |
Downie William | SVP, Global Sales & Marketing | 08/27/2018 | 56,365 |
Chiminski John R | Chair, President & CEO | 08/27/2018 | 427,126 |
Arnold Jonathan | President, Oral Drug Delivery | 08/27/2018 | 22,616 |
Miyamoto Lance | SVP, Human Resources | 08/27/2018 | 43,092 |
Maselli Alessandro | SVP, Global Operations | 08/27/2018 | 18,643 |
Littlejohns Barry | President, Biologics & SDD | 08/27/2018 | 41,215 |
Joseph Wetteny | SVP & Chief Financial Officer | 08/27/2018 | 21,917 |
HEGWOOD PAUL W JR | President, CSS | 08/27/2018 | 22,048 |
Gunther Scott | SVP, Quality & Reg. Affairs | 08/27/2018 | 25,759 |
Fasman Steven L | SVP & General Counsel | 08/27/2018 | 46,411 |
Downie William | SVP, Global Sales & Marketing | 08/27/2018 | 56,365 |
Chiminski John R | Chair, President & CEO | 08/27/2018 | 427,126 |
Arnold Jonathan | President, Oral Drug Delivery | 08/27/2018 | 22,616 |
Miyamoto Lance | SVP, Human Resources | 08/23/2018 | 89,056 |
Maselli Alessandro | SVP, Global Operations | 08/23/2018 | 15,435 |
Littlejohns Barry | President, Biologics & SDD | 08/23/2018 | 85,208 |
Joseph Wetteny | SVP & Chief Financial Officer | 08/23/2018 | 76,758 |
HEGWOOD PAUL W JR | President, CSS | 08/23/2018 | 18,196 |
Gunther Scott | SVP, Quality & Reg. Affairs | 08/23/2018 | 21,375 |
Fasman Steven L | SVP & General Counsel | 08/23/2018 | 96,000 |
Downie William | SVP, Global Sales & Marketing | 08/23/2018 | 116,580 |
Chiminski John R | Chair, President & CEO | 08/23/2018 | 734,577 |
Arnold Jonathan | President, Oral Drug Delivery | 08/23/2018 | 46,724 |
Fasman Steven L | SVP & General Counsel | 06/20/2018 | 457,658 |
Fasman Steven L | SVP & General Counsel | 06/20/2018 | 375,011 |
Fasman Steven L | SVP & General Counsel | 06/20/2018 | 94,089 |
Downie William | SVP, Global Sales & Marketing | 03/08/2018 | 530,917 |
Downie William | SVP, Global Sales & Marketing | 03/08/2018 | 405,239 |
Downie William | SVP, Global Sales & Marketing | 03/08/2018 | 379,628 |
Chiminski John R | Chair, President & CEO | 12/11/2017 | 4,971,512 |
Chiminski John R | Chair, President & CEO | 12/11/2017 | 2,213,596 |
Chiminski John R | Chair, President & CEO | 12/12/2017 | 3,089,287 |
Chiminski John R | Chair, President & CEO | 12/11/2017 | 4,099,740 |
Roehrhoff Uwe | Director | 11/21/2017 | 294,150 |
Fasman Steven L | SVP & General Counsel | 10/23/2017 | 68,469 |
Chiminski John R | Chair, President & CEO | 10/23/2017 | 154,035 |
Chiminski John R | Chair, President & CEO | 09/16/2017 | 870,320 |
Miyamoto Lance | SVP - Human Resources | 08/29/2017 | 892,131 |
Miyamoto Lance | SVP - Human Resources | 08/29/2017 | 475,135 |
Miyamoto Lance | SVP - Human Resources | 08/29/2017 | 325,329 |
Dolan Christine | SVP - Product Development | 08/29/2017 | 231,105 |
Dolan Christine | SVP - Product Development | 08/29/2017 | 169,915 |
Dolan Christine | SVP - Product Development | 08/29/2017 | 61,768 |
WALSH MATTHEW M | EVP & Chief Financial Officer | 08/24/2017 | 290,306 |
Miyamoto Lance | SVP - Human Resources | 08/24/2017 | 126,897 |
Maselli Alessandro | SVP - Global Operations | 08/24/2017 | 25,281 |
Littlejohns Barry | President - DDS | 08/24/2017 | 119,714 |
Joseph Wetteny | President - CSS | 08/24/2017 | 64,153 |
Gunther Scott | SVP, Quality & Reg. Affairs | 08/24/2017 | 30,597 |
Gennadios Aristippos | See Remarks | 08/24/2017 | 92,708 |
Fasman Steven L | See Remarks | 08/24/2017 | 134,784 |
Downie William | SVP, Global Sales & Marketing | 08/24/2017 | 198,725 |
Dolan Christine | SVP - Product Development | 08/24/2017 | 66,230 |
Chiminski John R | President & CEO | 08/24/2017 | 685,609 |
Dolan Christine | SVP - Product Development | 08/01/2017 | 25,963 |
WALSH MATTHEW M | EVP & Chief Financial Officer | 07/31/2017 | 112,953 |
Miyamoto Lance | SVP - Human Resources | 07/31/2017 | 49,378 |
Maselli Alessandro | SVP - Global Operations | 07/31/2017 | 24,584 |
Littlejohns Barry | President - DDS | 07/31/2017 | 46,580 |
Joseph Wetteny | President - CSS | 07/31/2017 | 24,899 |
Gunther Scott | SVP, Quality & Reg. Affairs | 07/31/2017 | 29,550 |
Downie William | SVP, Global Sales & Marketing | 07/31/2017 | 77,319 |
Dolan Christine | SVP - Product Development | 07/31/2017 | 25,668 |
Chiminski John R | President & CEO | 07/31/2017 | 133,446 |
WALSH MATTHEW M | See Remarks | 06/08/2017 | 1,735,814 |
WALSH MATTHEW M | See Remarks | 06/08/2017 | 884,064 |
Johnson Sharon | See Remarks | 04/25/2017 | 1,519,368 |
Johnson Sharon | See Remarks | 04/25/2017 | 1,047,668 |
Johnson Sharon | See Remarks | 04/25/2017 | 265,640 |
Downie William | See Remarks | 03/20/2017 | 1,190,398 |
Downie William | See Remarks | 03/20/2017 | 770,994 |
Downie William | See Remarks | 03/20/2017 | 236,293 |
Chiminski John R | See Remarks | 03/16/2017 | 3,786,653 |
Chiminski John R | See Remarks | 03/16/2017 | 2,213,586 |
Chiminski John R | See Remarks | 03/16/2017 | 2,106,756 |
Chiminski John R | See Remarks | 03/20/2017 | 5,781 |
MOREL DONALD E JR | Director | 02/15/2017 | 292,700 |
Blackstone Management Associates V L.L.C. | 10% Owner | 09/09/2016 | 403,234,623 |
Blackstone Management Associates V L.L.C. | 10% Owner | 06/09/2016 | 215,333,563 |
WALSH MATTHEW M | See Remarks | 05/27/2016 | 1,959,694 |
WALSH MATTHEW M | See Remarks | 05/27/2016 | 1,398,010 |
WALSH MATTHEW M | See Remarks | 05/27/2016 | 611,533 |
CARROLL J MARTIN | Director | 09/04/2015 | 81,780 |
Chiminski John R | See Remarks | 08/17/2015 | 2,078,531 |
Chiminski John R | See Remarks | 08/17/2015 | 1,071,000 |
Chiminski John R | See Remarks | 08/19/2015 | 100,263 |
Chiminski John R | See Remarks | 08/17/2015 | 1,201,590 |
Chiminski John R | See Remarks | 08/03/2015 | 2,190,873 |
Chiminski John R | See Remarks | 08/03/2015 | 1,071,000 |
Chiminski John R | See Remarks | 08/03/2015 | 1,194,126 |
WALSH MATTHEW M | See Remarks | 07/27/2015 | 1,755,123 |
WALSH MATTHEW M | See Remarks | 07/27/2015 | 974,229 |
WALSH MATTHEW M | See Remarks | 07/27/2015 | 847,223 |
Chiminski John R | See Remarks | 07/20/2015 | 1,967,419 |
Chiminski John R | See Remarks | 07/20/2015 | 1,071,000 |
Chiminski John R | See Remarks | 07/20/2015 | 972,581 |
Chiminski John R | See Remarks | 07/06/2015 | 1,941,486 |
Chiminski John R | See Remarks | 07/06/2015 | 1,071,000 |
Chiminski John R | See Remarks | 07/06/2015 | 992,514 |
Blackstone Management Associates V L.L.C. | 10% Owner | 06/11/2015 | 51,898,808 |
Blackstone Management Associates V L.L.C. | 10% Owner | 06/08/2015 | 345,992,042 |
WALSH MATTHEW M | See Remarks | 04/06/2015 | 2,068,844 |
WALSH MATTHEW M | See Remarks | 04/06/2015 | 1,092,881 |
WALSH MATTHEW M | See Remarks | 04/06/2015 | 1,047,979 |
Houlton Scott | See Remarks | 04/01/2015 | 2,018,301 |
Houlton Scott | See Remarks | 04/01/2015 | 1,174,870 |
Houlton Scott | See Remarks | 04/01/2015 | 497,504 |
Gennadios Aristippos | See Remarks | 04/01/2015 | 1,220,145 |
Gennadios Aristippos | See Remarks | 04/01/2015 | 734,573 |
Gennadios Aristippos | See Remarks | 04/01/2015 | 761,209 |
WALSH MATTHEW M | See Remarks | 03/27/2015 | 332,274 |
Leonard Stephen | See Remarks | 03/27/2015 | 2,522,303 |
Leonard Stephen | See Remarks | 03/27/2015 | 1,456,560 |
Leonard Stephen | See Remarks | 03/27/2015 | 934,181 |
Johnson Sharon | See Remarks | 02/17/2015 | 1,456,831 |
Johnson Sharon | See Remarks | 02/13/2015 | 926,739 |
Johnson Sharon | See Remarks | 02/17/2015 | 856,691 |
Johnson Sharon | See Remarks | 02/13/2015 | 529,074 |
Johnson Sharon | See Remarks | 02/13/2015 | 447,962 |
Johnson Sharon | See Remarks | 02/17/2015 | 676,314 |
Kurt Nielsen | See Remarks | 02/17/2015 | 1,162,979 |
Kurt Nielsen | See Remarks | 02/17/2015 | 765,979 |
Kurt Nielsen | See Remarks | 02/17/2015 | 797,384 |
Kurt Nielsen | See Remarks | 02/17/2015 | 768,576 |
Kurt Nielsen | See Remarks | 02/17/2015 | 514,508 |
Kurt Nielsen | See Remarks | 02/17/2015 | 548,200 |
Houlton Scott | See Remarks | 02/13/2015 | 53,534 |
Houlton Scott | See Remarks | 02/17/2015 | 494 |
Houlton Scott | See Remarks | 02/17/2015 | 334,259 |
Houlton Scott | See Remarks | 02/13/2015 | 35,268 |
Houlton Scott | See Remarks | 02/13/2015 | 39,592 |
Houlton Scott | See Remarks | 02/17/2015 | 360,244 |
Leonard Stephen | See Remarks | 02/13/2015 | 42,737 |
Leonard Stephen | See Remarks | 02/13/2015 | 26,861 |
Leonard Stephen | See Remarks | 02/13/2015 | 28,340 |
Downie William | See Remarks | 02/13/2015 | 142,699 |
Downie William | See Remarks | 02/17/2015 | 2,614,218 |
Downie William | See Remarks | 02/13/2015 | 66,423 |
Downie William | See Remarks | 02/17/2015 | 1,488,358 |
Downie William | See Remarks | 02/13/2015 | 30,089 |
Downie William | See Remarks | 02/17/2015 | 1,251,900 |
WALSH MATTHEW M | See Remarks | 02/13/2015 | 89,952 |
Load More Insider Transactions
FUNDS WITH A POSITION IN CATALENT, INC.
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 15,354,327 | 0.02% | 1.04% | Other |
CAPITAL WORLD INVESTORS | 4,911,723 | 0.05% | -62% | Growth At A Reasonable Price |
VERITAS ASSET MANAGEMENT LLP | 4,395,354 | 1.87% | -27.05% | Growth At A Reasonable Price |
BALYASNY ASSET MANAGEMENT L.P. | 4,373,951 | 0.43% | 373.16% | Event Driven |
GEODE CAPITAL MANAGEMENT, LLC | 4,310,664 | 0.02% | 3.27% | Other |
ELLIOTT INVESTMENT MANAGEMENT L.P. | 4,000,000 | 1.3% | No change | Activists |
TIG ADVISORS, LLC | 1,434,896 | 5.81% | New | Event Driven |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,345,794 | 0.14% | 62.67% | Other |
WESTCHESTER CAPITAL MANAGEMENT, LLC | 1,130,177 | 2.39% | 15.12% | Event Driven |
MAGNETAR FINANCIAL LLC | 995,550 | 1.17% | -0.41% | Event Driven, Other |
WATER ISLAND CAPITAL LLC | 537,856 | 3.21% | -1.29% | Event Driven |
AQR ARBITRAGE LLC | 358,167 | 0.52% | -33% | Event Driven |
TUDOR INVESTMENT CORP ET AL | 518,680 | 0.15% | 298.59% | Event Driven, Other |
SAND GROVE CAPITAL MANAGEMENT LLP | 487,194 | 8.01% | 167.22% | Value |
GABELLI FUNDS LLC | 445,671 | 0.19% | -2.3% | Event Driven, Growth, Activists |
MELQART ASSET MANAGEMENT (UK) LTD | 397,725 | 1.85% | New | Event Driven |
TIG ADVISORS, LLC | 320,000 (Put) | 1.3% | New | Event Driven |
D. E. SHAW & CO., INC. | 260,893 | 0.01% | New | Other |
WATER ISLAND CAPITAL LLC | 100,000 (Call) | 0.00057% | Exited | Event Driven |
ALPINE GLOBAL MANAGEMENT, LLC | 67,868 | 0.66% | -15.17% | Event Driven |
WESTCHESTER CAPITAL MANAGEMENT, LLC | 50,000 (Put) | 0.1% | Exited | Event Driven |
BRIDGEWATER ASSOCIATES, LP | 34,147 | 0.01% | New | Other |
BLACKSTONE INC. | 14,315 | 0.00336% | -41.2% | Other |
CANDRIAM S.C.A. | 15,639 | 0.00533% | 13.11% | Other |
AQR CAPITAL MANAGEMENT LLC | 10,675 | 0.00092% | 7.56% | Other |
GOTHAM ASSET MANAGEMENT, LLC | 4,498 | 0.00327% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR CATALENT, INC.
STOCK BUYBACKS FOR CATALENT, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 06/30/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2024
0.13%
1Q
12/31/2023
0.19%
2Q
09/30/2023
0.39%
3Q
06/30/2023
0.39%
4Q
03/31/2023
0.49%
5Q
12/31/2022
0.56%
6Q
09/30/2022
0.60%
7Q
06/30/2022
0.99%
8Q
03/31/2022
1.05%
9Q
12/31/2021
5.72%
10Q
09/30/2021
5.97%
11Q
06/30/2021
6.25%
12Q
03/31/2021
6.32%
13Q
12/31/2020
9.89%
14Q
09/30/2020
10.26%
15Q
06/30/2020
16.84%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CATALENT, INC.
LOADING...